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We  have  previously  shown  that  human  mesenchymal  stromal  cells  dedifferentiate  to  
early  mesoderm  when  cultured  in  defined  three-­dimensional  (3D)  in  vitro  conditions,  
to   mimic   mesenchymal   condensation,   through   a   controlled   autophagy   response.  
Here   it   was   determined   if   human   dermal   fibroblasts   (HDFs),   a   terminally  
differentiated  cell,  could  similarly  undergo  dedifferentiation.  By  varying  initiating  cell  
number   and   culture   duration,   we   identified   optimised   conditions   for   HDF  
dedifferentiation   in  3D  spheroids.  This  was  revealed  by  QPCR  which   identified   low  
level  expression  of  pluripotency  factors,  Oct4,  Sox2  and  Nanog,  and  a  6  to  1200-­fold  
increase  in  mesodermal  markers,  Brachyury,  Goosecoid  and  CXCR4,  compared  to  
adherent   2D   HDFs,   whilst   expression   of   the   CXCR4   ligand   and   stromal   marker  
CXCL12   decreased.   CXCR4   protein   expression   was   confirmed   by   western   blot  
analysis   and   immunostaining,   which   showed   positive   distribution   across   the  
spheroid.   These   changes   occurred   with   a   concomitant   increase   in   autophagic  
features   (increased   TFEB   mRNA   expression,   elevated   LAMP-­1   protein   and   the  
accumulation  of  autophagosome-­like  structures).  We  next  tested  the  redifferentiation  
potential   of   3D   HDFs   by   exposing   the   disaggregated   cells   to   endothelial   growth  
conditions  on  Matrigel.  When  exposed  to  EGF  and  FGF-­2,  endothelial-­like  networks  
formed   within   7   days,   which   was   reduced   to   24h   following   the   addition   of   IGFI,  
VEGF  and  BMP4.  These  cells  were  also  shown  to  express  low  levels  of  endothelial  
cell  markers,  VE-­Cadherin,  Nrp1,  Nrp2  and  ALK1  and  higher   levels  of  EphB4  and  
KDR   by   QPCR.   These   findings   suggest   that   human   cell   differentiation   can   be  
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1   Introduction  
  
1.1   Introduction  to  Regenerative  Medicine:  
  
The  aim  of  regenerative  medicine  is  to  replace  or  regenerate  human  cells,  tissues  or  
organs  to  restore  the  original  function.  Regenerative  medicine  by  definition  covers  a  
wide   range   of   therapeutic   approaches   spanning   from   the   administration   of   small  
molecules  to  cell  based  therapies.  Since  humans  only  possess  a  limited  capacity  to  
repair   and   replenish   damaged   tissues   and   organs   this   makes   restorative   cell  
therapies   mimicking   either   development   or   natural   examples   of   regeneration   a  
desirable   commodity.   During   human   foetal   development   highly   proliferative  
multipotent   cells   progress   into   an   adult   phenotype   that   is   no   longer   capable   of  
regenerating   original   tissue   (van   de   Ven   et   al.,   2007).   Thus   adult   cell   damage   is  
usually  ‘patched’  up  using  fibroblasts  and  through  the  substitution  of  a  cellular  matrix  
resulting  in  fibrogenesis  and  the  formation  of  disorganised  collagen  deposits  i.e  scar  
tissue  (Gurtner  et  al.,  2008).  The  resulting  fibrosis  can  be  detrimental  as  evidenced  
by   fibrotic   cardiac   tissues,   which   have   no   regenerative   capabilities   and   is   a  
contributor  to  heart  failure  (Chen  and  Frangogiannis,  2010).  Wound  repair  occurs  in  
the   majority   of   tissues   therefore   damage   due   to   a   myocardial   infarction   can   be  
compared  and  is  similar  to  the  repair  of  a  burn  or  spinal-­cord  injury  (Gurtner  et  al.,  
2008).   Scar   tissue   usually   has   less   tensile   strength   and   acquires   a   rigid  
characteristic  meaning  that  tissues  that  require  integrity,  such  as  skin  which  acts  as  
a  protective  barrier,  become  more  fragile  (David  T  Corr,  2009).  Tissue  damage  is  a  
major   cause   for   concern   and   a  main   focus   for   regenerative   therapies.  Myocardial  
infarction   causes   tissue  within   the   heart   to   become   necrotic   and   the   body   repairs  
this  through  substitution  of  the  necrotic  tissue  by  scar  tissue  (Ørn  et  al.,  2007).  The  
remaining  muscle  in  the  heart  is  thought  to  compensate  for  initial  ventricular  function  
(Khan  and  Sheppard,  2006).  However,  despite  this  compensation,  the  development  
of   scar   tissue   has   been   associated   with   stiffness,   hypertrophy   and   heart   failure  
(Conrad   et   al.,   1995).   Therefore   one   approach   has   been   to   develop   a   cell   based  
therapy   in   an   attempt   to   restore   the   missing   tissue   with   in   vitro   grown  
cardiomyocytes.   This   aims   to   avoid   the   formation   of   scar   tissue   and   restore   the  
heart  back  to  its  original  functional  state  (Ieda  et  al.,  2010;;  Zhang  et  al.,  2015;;  Zwi  et  
al.,  2009).  This  and  other  medical  burdens  due  to  the  limited  repair  capacity  of  adult  
tissues  have  prompted   researchers   to   create  new   therapeutic   cell   types   in   vitro   in  
order   to   recapitulate   developmental   processes   that   originally   created   the   organ  




Other   methods   could   potentially   create   in   vitro   or   in   vivo   situations   that   mimic   to  
some   extent   regeneration   typically   seen   in   lower   organisms   such   as   zebra   fish  
(Danio   rerio)   caudal   fin   regeneration   or   newt   (Salamandridae)   lens   regeneration.  
Multiple  pathways  that  are  necessary  for  regeneration  in  humans  are  currently  being  
researched  in  order  to  discover  new  potential  therapies.    
  
1.2   Tissue  regeneration  in  vivo:  
  
There   are   multiple   different   examples   of   organisms   that   have   the   potential   to  
partially   or   fully   regenerate   organs   and   whole   limbs.   Humans   generally   tend   to  
display  poor  regenerative  ability,  with  the  exception  of  liver  regeneration.  In  contrast,  
lower  organisms  such  as  salamanders  show  a  much  greater   regenerative  capacity  
and  can  fully  regenerate  many  body  parts  including  limb,  tail,  eye,  jaw  and  the  heart  
(Tanaka,  2003).  There  are  different  processes  in  which  different  organisms  replace  
damaged  or  amputated  tissues.  Human  liver   is  known  for   its  ability   to  restore   itself  
and   allows   us   to   successfully   transplant   a   liver   lobe   (Botha   et   al.,   2010).   Liver  
regeneration  occurs  through  a  pool  of  adult  stem  cells  known  as  ‘Hering  Canal  Cell’  
(Neil  D.  Theise,  1999).  These  cells  are  capable  of  differentiating  via  a  precursor  cell  
called   oval   cells   into   various   cell   types   including   hepatocytes   and   biliary   cells   to  
replace   and   restore   damaged   tissue   (Fausto,   2000;;   Fausto   and  Campbell,   2003).  
This  method  of  regeneration  requires  a  pool  of  adult  stem  cells  to  repair  the  tissue.  
However,   there   is   no   dedifferentiation   or   reprogramming   necessary.   This   is   one  
method   by   which   cell   therapies   could   be   implemented,   but   the   cells   would   be  
differentiated   in   vitro   and   transplanted   to   replace   the   damaged   or   missing   cells.  
Adult   stem   cells   can   be   of   use   in   in   vitro   tests   in   order   to   create   new   cell   based  
therapies  and  bone  marrow  derived  mesenchymal  stromal  cells  (MSCs)  in  particular  
have  been  of  great  interest  (Wei  et  al.,  2013).  However,  certain  adult  stem  cells  are  
more  difficult  to  harvest  than  other  adult  cells  and  this  is  frequently  due  to  restricted  
or   inaccessible   location   and   the   fact   there   are   such  a   small   number   of   stem  cells  
(Young   and   Black,   2004).   Specific   adult   stem   cells   need   to   be   used   for   specific  
injury  repair;;  once  again  using   the  example  of  MSCs  they  would  generally  have  to  
be  used  in  bone  regeneration  or  other  skeletal  tissues  into  which  MSCs  differentiate  
(Wei  et  al.,  2013).    
Two   main   methods   of   natural   regeneration   without   the   use   of   adult   stem   cells  




the  cells  are  reverted  back  to  an  earlier  form  which  is  still  committed  to  a  certain  cell  
type  but  it  regains  a  capability  it  lost  during  the  final  stages  of  differentiation  such  as  
the  ability  to  proliferate  (Jopling  et  al.,  2011).  This  method  of  natural  dedifferentiation  
is   used   by   zebra   fish   as   a   method   to   regenerate   cardiomyocytes   to   replace   lost  
ventricular   tissue.  These  fish     have  been  shown  to  be  capable  of   repairing  up  to  a  
20%  amputation   of   the   ventricle   (Jopling   et   al.,   2010;;  Poss   et   al.,   2002).  When   a  
piece   of   the   ventricle   is   removed   or   damaged   the   remaining   fully   differentiated  
cardiomyocytes,   with   nearly   no   proliferative   capacity,   dedifferentiate   to   a  
cardiomyocyte  precursor  cell  (Takeuchi,  2014;;  Zhang  et  al.,  2010).  This  allows  them  
to   proliferate   before   redifferentiating   to   regenerate   missing   tissue   (Jopling   et   al.,  
2010;;   Lepilina   et   al.,   2006).   This   dedifferentiation   is   thought   to   occur   due   to   the  
dedifferentiation  of  the  contractile  apparatus  and  allows  it  to  disassemble  to  prevent  
the  sarcomere  from  physically   impeding  cytokinesis.    This  means  that  the  cells  are  
capable  of  dividing  and  replacing  the  damaged  tissue.    
Transdifferentiation   is   a   process   that  may   also   lead   to   the   regeneration   of   lost   or  
damaged   tissue.   Transdifferentiation   occurs   when   an   existing   terminally  
differentiated   cell   is   converted   into   a   different   cell   type   that   is   required   by   the  
organism   (Jopling   et   al.,   2011).   This   differs   to   natural   dedifferentiation   as   the   cell  
type  changes  completely  as  opposed   to  dedifferentiating   to  a  precursor  of   the  cell  
type  in  question  and  then  redifferentiating  back  to  the  same  cell  type.  The  method  of  
transdifferentation   varies   between   organisms.   However,   the   majority   of   natural  
transdifferentiation  requires  some  form  of  dedifferentiation  before  the  cells  can  form  
the  required  cell   type.  An  example  of  transdifferentiation  occurring  in  nature  is   lens  
regeneration   in   newts   (Maki   et   al.,   2010;;   Tsonis   et   al.,   2004).   When   the   lens   is  
removed,  pigmented  epithelial  cells  (PECs)  from  the  dorsal  iris  transdifferentiate  and  
regenerate   the  missing   tissue  (Tsonis  et  al.,  2004).  They  are  capable  of  doing   this  
through   their   ability   to   dedifferentiate   to   a   point   where   they   can   switch   their  
developmental  fate.  The  cells  elongate  and  become  columnar  and  depigmented  and  
genes   such   as   FGF   (fibroblast   growth   factor)   and   PROX-­1   (Prospero   homeobox  
protein-­1)   that   are   known   to   be   involved   in   lens   production   are   also   expressed  
during   the   regeneration   (Tsonis   et   al.,   2004).   Once   differentiation   is   reinitiated,  
specific  parts  of   the  aggregate  of  PECs     are  capable  of   forming  parts  of   the   lens.  
Some  dedifferentiated  PECs  induce  crystallin  synthesis  and  others  create  lens  fibres  
and  lens  epithelium  which  then  continues  to  proliferate  and  differentiate  to  form  the  




Another   example   of   a   natural   regeneration   process   is   total   limb   regeneration   in  
newts  which  occurs   through   the   formation  of   a   blastema.   If   the   limb   is   amputated  
between  the  shoulder  to  fingertip  area,  the  wound  is  quickly  coated  in  epithelial  cells  
to  form  a  wound  epidermis  (Brockes,  1997).  This  differs  to  lens  regeneration  which  
is   due   to   plasticity   of   the   pigmented   epithelial   cells.   In   contrast   during   limb  
regeneration,  mesenchymal  cells  underneath  the  wound  epidermis  re-­enter  the  cell  
cycle  and   form  blastemal   cells  with  proliferating  dedifferentiated   cells   just   beneath  
the   apical   ectodermal   cap   (Figure   1.1)   (Gilbert,   2000).   These   cells   form   what   is  
known  as    a  blastema  which   is  an  area  from  which   it   is  possible   to  regenerate  the  
limb   (Figure   1.1)   (Brockes,   1997;;   Brockes   and  Kumar,   2002;;   Tsonis,   1996).   Limb  
blastemal   cells  will   always  give   rise   to  a   limb  due   to   the   fact   the   cells   are  usually  
only  capable  of  differentiating  into  a  local  progenitor  cell  rather  than  going  through  a  
transitional  phase  as  a  pluripotent  cell  (Kim  and  Stocum,  1986).    
These   natural   occurrences   of   cell   reprogramming   have   prompted   researchers   to  
elucidate   the  mechanisms  by  which   these  organisms  regenerate  and   to  attempt   to  
replicate   these  mechanisms   in  vitro   to  create  potential   therapies   to   treat   injuries   in  
human  tissues.  
	  
Figure  1.1  Formation  of  Blastema  during  Limb  Regeneration  
The   wound   is   quickly   coated   in   epithelial   cells   to   form   the   wound   epidermis   and   the  
mesenchymal  cells   found   in   the   limb  move   to   the  wound  and  become  dedifferentiated  
blastemal   cells   to   form   what   is   known   as   the   blastema   (B).   This   is   then   capable   of  




1.3   Tissue  regeneration  in  vitro:  
  
Regenerative   medicine   has   often   focussed   on   understanding   and   mimicking  
developmental  processes  through  the  manipulation  of  adult  cells  to  create  new  cell  
types.    One  main  area  of  research  involves  inducing  dedifferentiation  in  vitro  through  
various  methods,  including  the  introduction  of  specific  factors.  A  large  proportion  of  
potential   cell   therapies   involve   the   use   of   induced   pluripotent   stem   cells   (iPSCs).  
iPSCs   were   generated   by   the   introduction   of   several   important   early   transcription  
factors  through  retroviral  tranduction  into  human  dermal  fibroblasts.  This  was  initially  
done   using   mouse   dermal   fibroblasts   and   then   using   human   dermal   fibroblasts  
(Takahashi   and   Yamanaka,   2006;;   Takahashi   et   al.,   2007).   This   method  
reprogrammes   the   cells   to   a   pluripotent   state   through   the   introduction   of   factors  
including  a  combination  of  Oct4  (POU5F1),  KL4,  Sox2  and  cMyc  or  a  combination  of  
Oct4,   Sox2,   Nanog   and   Lin28   (Takahashi   et   al.,   2007;;   Yu   et   al.,   2007).   These  
factors   had   previously   been   confirmed   to   be   involved   in  maintaining   pluripotency.  
The  creation  of  iPSCs  allows  the  production  of  an  artificial  pluripotent  cell  type  which  
has   the  capacity   to  differentiate   into  cells   from  all   three  germ   layers   (Hochedlinger  
and   Jaenisch,   2006).   In   vitro   differentiation   protocols   using   iPSCs   can   then   be  
developed   to  produce   the  desired  cell   types.  Various  differentiation  protocols  have  
been   described   and   related   to   the   work   presented   here,   it   has   been   shown   that  
human   iPSCs   are   capable   of   forming   a   mixed   population   of   endothelial-­like   cells  
(Choi  et  al.,  2009;;  Kurian  et  al.,  2013).  There  has  even  been  evidence   to  suggest  
that  the  specific  subtypes  of  endothelial  cells,  arterial,  venous  and  lymphatic,  can  be  
produced  (Marcelo  et  al.,  2013).  One  method  of  differentiating  iPSCs  involves  using  
a  feeder  layer,  in  this  case  OP9  feeder.  The  iPSCS  are  cultured  with  the  OP9  cells  
feeders  in  α-­MEM  supplemented  with  10%  FBS  and  100μM  monothioglycerol  (Choi  
et   al.,   2009).   The   cells   were   shown   to   express   endothelial   markers   VE-­cadherin,  
KDR   and   CD31.   They   were   also   capable   of   forming   capillary-­like   networks   on  
Matrigel  when  grown  in  the  presence  of  FGF-­2  and  vascular  endothelial  cell  growth  
factor  (VEGF)  (Choi  et  al.,  2009).  Further  research  has  shown  that   it   is  possible  to  
direct   endothelial   cell   development   towards   specific   subtypes.   During   vascular  
remodeling,  endothelial  cells  specialise   to  acquire   the  phenotypes  and  functions   to  
create  all  three  endothelial  subtypes  (dela  Paz  and  D’Amore,  2009;;  Podgrabinska  et  
al.,  2002).  These  different  subtypes  are  necessary  as  arterial  cells  need  to  withstand  
higher   blood   pressures   when   compared   to   venous   cells.   This   preferential  
differentiation   is   thought   to  be  achieved   through  dose-­dependent   regulation  of   key  




al.,   2005;;   Marcelo   et   al.,   2013).   The   concentration   of   VEGF   is   essential   for  
suppressing  or  activating  a   specific   endothelial   cell   phenotype.   It   is   thought   that  a  
high   concentration   of   VEGF   induces   arterial   cell   differentiation   but   low   to  
intermediate   amounts   induce   venous   specification   (Marcelo   et   al.,   2013).   Other  
factors  involved  such  as  COUP-­TII  promote  venous  differentiation.  However,  the  full  
mechanism  is  still  not  fully  understood.  The  expression  of  certain  factors  are  used  to  
characterize   the  specification  of  endothelial  cell  subtype.  For  example  EPHB4  and  
Nrp-­2   (Herzog   et   al.,   2005;;   Marcelo   et   al.,   2013)   are   expressed   by   venous  
endothelium  and  ALK1,  CXCR4,  and  Nrp-­1  (Corti  et  al.,  2011;;  Herzog  et  al.,  2005;;  
Kurian   et   al.,   2013)   are   known   to   be   arterial   endothelial   markers.   VE-­cadherin   is  
often  used  as  a  lymphatic  endothelial  cell  marker  (Kurian  et  al.,  2013).  
Despite  the  possibilities  of  using  the   iPSCs  for  producing  a  desired  cell-­type,  other  
approaches   that   do   not   require   forced   expression   of   pluripotency   factors   are   also  
desirable.  This   is  due   to   concerns   regarding   the  safety  and  efficiency  of   the   iPSC  
process.  Research   into   regenerating   tissues   in  vivo  has  elucidated  specific   factors  
and  mechanisms  necessary  for  the  repair  of  specific  tissues.  Earlier  dedifferentiation  
and   transdifferentiation   in   vivo   were   discussed   including   the   examples   of  
cardiomyocyte  restoration  and  newt   lens  regeneration  (Poss  et  al.,  2002;;  Tsonis  et  
al.,   2004).   Following   the   findings   in   zebra   fish   concerning   cardiomyocyte  
dedifferentiation   and  proliferation,   this   process  has   been  mimicked   in   vitro   (Figure  
1.2).  Now   it   is   possible   to   induce   human   cardiomyocytes   to   undergo   senescence  
withdrawal   to   allow   the   cardiomyocytes   to   proliferate   and   redifferentiate   back   into  
functional   cardiomyocytes   (Zhang  et   al.,   2010).  The  ability   to  produce  proliferative  
cardiomyocytes  has  an  important  therapeutic  potential  as  it  would  give  us  the  ability  
to   restore  damaged  heart   tissue  which  has   restricted   repair   capability   and   tend   to  
form   scar   tissue.   Using   dedifferentiation   in   this   way   usually   involves   the  
maintenance   of   the   specific   cell   type   but   at   an   earlier   stage.   Studies   on   human  
cardiomyocytes   have   shown   that   it   is   also   possible   to   induce   cardiomyocyte  
proliferation  through  the  dedifferentiation  of   the  contractile  apparatus  (Zhang  et  al.,  
2010).   p38   MAP   kinase   is   known   to   regulate   necessary   genes   for   mitosis   in  
cardiomyocytes   such   as   cyclin   A   and   cyclin   B   (Ambrosino   and   Nebreda,   2001;;  
Engel  et  al.,  2005),  Adler  et  al.,  2007).  Overexpression  of  p38  MAPK  is   thought   to  
block  cardiomyocyte  proliferation  and  cells  with  a  p38  MAPK  inhibitor  are  shown  to  
undergo   higher   levels   of   proliferation.   FGF-­1   also   plays   a   role   as   it   is   known   to  
upregulate   genes   implicated   in   regeneration   and   cell   cycle   control.   Therefore,  




is  possible   to  dedifferentiate  cardiomyocytes   to  a  stage  where   they  are  capable  of  
proliferating  (Figure  1.2)  (Engel  et  al.,  2005).      
  
	  
Figure  1.2  Dedifferentiation  of  Cardiomyocytes  to  Proliferative  Progenitor  Cells.  
Cardiomyocytes   are   capable   of   dedifferentiating   to   a   progenitor   cell   that   is   capable   of  
proliferating.  This  allows   the  cardiomyocytes   that   typically  do  not  proliferate   to   re-­enter  
the  cell  cycle  and  divide  to  replenish  damaged  or  amputated  cells.  
	  
Recent   evidence   has   shown   that   it   is   possible   to   transdifferentiate   cells   in   a  
therapeutic  manner.  An  example  of   this   is   the  transdifferentiation  of  human  dermal  
fibroblasts   to   endothelial   cells.   It   was   hypothesised   that   to   induce   fibroblast   to  
endothelial   cell   transdifferentiation,  endothelial   cell   specification  could  be  achieved  
by   small   molecule   activators   of   toll-­like   receptor   3   (TLR3)   together   with   micro-­
environmental  conditions   (Sayed  et  al.,  2014).  The  human  dermal   fibroblasts  were  
grown  on  gelatin-­coated  plates  and   treated  with  Poly   I:C   in  medium  supplemented  
with  serum  and  a  gradually  increasing  concentration  of  knockout  serum  replacement  
(Figure  1.3)  (Sayed  et  al.,  2014).  Once  the  cells  had  been  treated  like  this  for  seven  
days,   then   the   cells   were   treated   with   a   transdifferentiation   medium   containing  
20ng/ml  BMP4,  50ng/ml  VEGF  and  20ng/ml  FGF-­2  (Figure  1.3)  (Sayed  et  al.,  2014).  
The   transdifferentiated  cells  were  maintained   in  medium   in   the  presence  of  FGF-­2  
and  VEGF  and  0.1mM  8-­bromoadendosine-­3’:  5’-­cyclic  monophosphate  sodium  salt  
(8-­Br-­cAMP)  which  is  known  to  increase  endothelial  cell  specification  (Sayed  et  al.,  
2014).  78%  of  cells  were  shown  to  express  CD31  which  is  an  endothelial  cell  marker  
and   they   also   expressed   endothelial   cell   (EC)   markers   VE-­cadherin,   KDR,   Von  
Willebrand  factor  (vWF)  and  eNOS.  Additionally,  the  cells  were  tested  for  their  ability  
to  form  capillaries  on  Matrigel  (Figure  1.3)  which  revealed  that  they  were  capable  of  




use   additional   supplements   insulin-­like   growth   factor   (IGF),   cortisol   and   heparin  
(Soda  et  al.,  2011).  These  cells  also  showed  CD31,  vWF  and  KDR  expression.    
The  ability  to  produce  cardiomyocytes  and  endothelial  cells  without  the  use  of  iPSCs  
provides   promising   evidence   that   environmental   cues   and   specific   differentiation  
factors  are  enough  to  cause  a  change  in  cell-­type.  
  
	  
Figure  1.3.  Transdifferentiation  of  HDFs  to  Endothelial  Cells  
HDFs  have  been  used  in  transdifferentiation  protocols  to  create  endothelial  cells.  This  is  
achieved  through  dedifferentiation  to  a  mesodermal  progenitor  cell.  Then  the  addition  of  
FGF-­2,   BMP4   and   VEGF   to   differentiate   cells   to   endothelial   cells   that   express   vWF,  












1.4   Issues  involving  current  in  vitro  methods  of  reprogramming:  
  
Despite   the   possible   benefits   of   using   iPSCs   to   create   cells   for   potential  
transplantation  and   therapies,   the  progress  of   cell   therapies  using   iPSCs  depends  
on   the   establishment   of   a   safe   and   efficient   method   of   genetic   manipulation.  
Transduction   is   a   popular   route   and   is   usually   carried   out   by   the   introduction   of  
retroviral   vectors   (Imamura   et   al.,   2012;;   Nethercott   et   al.,   2011).   Retroviral  
transduction  often   involves  the  use  of  modified  murine   leukaemia  virus  (MLV).  The  
use   of   viruses   is   often   necessary   as   the   virus   DNA   forms   a   large   nucleoprotein  
structure  which  contains  proteins  necessary   for   insertion  of  viral  DNA  into   the  host  
genome.   Hence,   despite   the   method   being   successful   in   inducing   pluripotency  
concerns   remain   about   safety   and   efficacy.   Retroviral   transduction   can   be   an  
efficient   methods   of   introducing   genes   into   a   host   genome.   However,   retroviral  
transduction  is  dependent  on  a  high  division  rate  which  varies  between  cultured  cell  
types  and  also  makes  it  non-­applicable  to  quiescent  cells  (Li  et  al.,  2004).  A  different  
form   of   transduction   known   as   lentiviral   transduction   which   involves   the   use   of  
modified   human   immunodeficiency   virus   (HIV)   is   capable   of   transducing   specific  
quiescent  cells.  This  means  lentiviral  transduction  is  becoming  increasingly  popular  
(Naldini   et   al.,   1996;;   Verhoeyen   et   al.,   2009).   A   bigger   issue   with   retroviral  
transduction  is  the  non-­specific  integration  of  DNA  into  the  host  cell  and  the  number  
of   insertions   can   vary   potentially   altering   transcription   within   the   cell.   It   has   also  
been   found   that   the   transcription  of   transduced  genes  can  resume   in  differentiated  
iPSCs   which   could   make   it   dangerous   to   use   virally   transduced   iPSCs   in   clinical  
trials  (Okita  et  al.,  2007).  This  may  be  problematic  for  example  when  the  viral  DNA  
integrates   and   activates   nearby   oncogenes   (Persons,   2010).   There   have   been  
examples   of   this   in   clinical   trials   of   X-­SCID   disorder   that   were   treated   with  
haematopoietic  stem  cells  transduced  with  a  recombinant  retrovirus  expressing  the  
common   gamma   chain   of   interleukin   receptor   (Hacein-­Bey-­Abina   et   al.,   2008).  
Despite   the   success   that   nine   out   of   eleven   patients   treated   had   almost   fully  
restored   immune   systems,   four   of   these   nine   patients   developed   T-­cell   acute  
lymphoblastic   leukaemia   between   three   and   six   years   after   treatment.   It   was  
confirmed  that  two  of  these  patients  had  a  copy  of  the  vector  DNA  found  in  the  first  
intron  of  the  growth-­promoting  LM02  gene  of  the  leukaemic  clones  and  upstream  of  
the   first   exon   of   the   same   gene   (Hacein-­Bey-­Abina   et   al.,   2008).   LM02   is   a   LIM  
domain  transcription  regulator  that  is  known  to  be  involved  in  haematopoiesis  and  is  
reported  to  be  activated  in  T  cell  leukaemia  by  chromosomal  translocation  (Yamada  




treatment   in   a   separate   clinical   trial   proving   that   genes  were   being   integrated   into  
the   host   (Hacein-­Bey-­Abina   et   al.,   2003).   This   illustrates   some   of   the   concerns  
regarding  the  use  of  cells  that  have  been  altered  by  retroviral  transduction  (Hacein-­
Bey-­Abina  et  al.,  2008).  Clinical  trials  using  lentiviral  transduced  cells  are  being  held  
and  safety  needs  to  be  further  assessed.  Additionally,  there  is  also  danger  of  ectopic  
transcription  of  Oct4,  Sox2,  Klf4  and  cMyc  leading  to  neoplastic  development  due  to  
their   association   with   the   development   of   multiple   tumours   (Ben-­David   and  
Benvenisty,  2011).    
In  addition,   there   is   the  concern   that  pluripotent   stem  cells  are  capable  of   forming  
teratomas.   There   have   been   many   different   cases   where   cells   that   were   derived  
from  pluripotent  cells  have  formed  teratomas  in  the  host.   iPSCs  are  known  to  form  
teratomas   when   transplanted   into   mice   and   therefore   have   the   same   adverse  
potential  for  the  host  (Ben-­David  and  Benvenisty,  2011).  Therefore  this  means  that  a  
main   focus   of   the   ability   to   use   iPSCs   in   therapies   is   the   requirement   to   prevent  
teratoma   formation   (Lee   et   al.,   2013).   However,   this   hurdle   could   potentially   be  
avoided  by  using  cell  therapies  avoiding  pluripotency.  
  
1.5   Embryonic  Specification  During  Early  Development:  
  
  Gastrulation   marks   the   beginning   of   morphological   patterning   within   the   embryo  
(Ginsburg   et   al.,   1990).   This   is   the   stage   at   which   a   blastocyst   is   formed   which  
consists   of   trophectoderm   and   the   inner   cell   mass   (ICM)   (Watson,   1992).  
Trophectoderm  forms  a  fluid  filled  cavity  and  provides  the  embryo  with  nutrients  and  
gives  rise  to  the  chorionic  sac  and  the  foetal  component  of  the  placenta  and  the  ICM  
where   the   pluripotent   progenitor   cells   are   located   which   develop   into   each   of   the  
three  germ   layers  during  gastrulation   (Boroviak  et   al.,   2014).  The   formation  of   the  
full  embryo  and  development  of  the  germ  layers  is  thought  to  be  controlled  through  
cell-­cell   interactions  and  cell-­matrix   interactions  and  also  through  the  expression  of  
specific   factors   to  allow   the   formation  of   individual   tissues   (Figure  1.4)   (Poh  et  al.,  
2014).  Due  to  the  fact  that  pluripotent  factors  act  to  maintain  pluripotency  therefore  
preventing  differentiation  they  must  be  downregulated  in  a  specific  manner  while  the  
expression   of   other   differentiation-­promoting   factors   is   upregulated   in   order   to  
determine   cell   fate.   Oct4   and   Sox2   are   closely   involved   in   germ-­layer   fate  
specification  by  enabling  cells  to  integrate  signals  and  thereby  determining  their  fate  




Oct4  has  been  found  to  be  upregulated  in  cells  committed  to  a  mesendodermal  fate  
but   repressed   in   the  neural  ectoderm  fate  (Pan  et  al.,  2002).  Sox2   is  expressed   in  
neural   ectoderm   as   opposed   to   mesendoderm   (Avilion   et   al.,   2003a).   Hence  
expression   levels   of   these   two   factors   are   controlled   to   allow   specific   lineages   to  
form.  With  high  Oct4  and  low  Sox2  mesendoderm  is  formed.  With  low  Oct4  and  high  
Sox2  neural  ectoderm  is  formed  (Avilion  et  al.,  2003b;;  Nichols  et  al.,  1998;;  Niwa  et  
al.,  2000;;  Pan  et  al.,  2002).  Downregulation  of  Nanog  has  also  been  shown  to  be  a  
necessary  step  during  lineage  specification.    
  
	  
Figure  1.4.  Human  Blastocyst  Structure  and  Germ  Layer  Locations.  
The  gastrulation  stage  of  development  is  when  the  three  germ  layers  are  starting  to  form  
and  specific   transcription   factors  used   to   identify  specific  germ   layers  are  beginning   to  
be  expressed.  
  
The  different  germ  layers  are  necessary  for   the  formation  of  different   tissues  types  
that  will   eventually   create   the   embryo.   As   previously  mentioned   these   three   germ  
layers   develop   from   the   ICM.   The   three   germ   layers   are   known   as   ectoderm,  
endoderm   and   mesoderm   which   can   be   located   in   specific   locations   of   the  
blastocyst   during   gastrulation   (Figure   1.4).   Ectoderm   generates   the   outer   layer   of  
the  embryo  and  develops   into   the  neural   crest,   neural   tube  and   surface  ectoderm  




These  develop  into  the  peripheral  nervous  system,  the  spinal  cord  and  epidermis  to  
name   a   few   examples   of   tissues   with   ectodermal   origin   (Chang   and   Hemmati-­
Brivanlou,  1998).  Ectodermal  tissues  are  typically  identified  through  certain  markers  
including  Fgf5,  Otx2,  Sox1  and  pax6  (Dimanlig  et  al.,  2001;;  Okita  et  al.,  2007;;  Pevny  
et  al.,  1998;;  Rathjen  et  al.,  1999).  Endoderm  develops  into  the  interior  linings  of  the  
digestive   and   respiratory   tube   (Zorn   and   Wells,   2009).   Thus,   endodermal  
differentiation  and  patterning  leads  to  the  formation  of  the  liver,  pancreas  and  lungs  
(Kubo  et  al.,  2004;;  Zorn  and  Wells,  2009).  Endodermal   tissues  are   identified  using  
specific  markers  such  as  Gata4,  Gata6  and  Sox17   (Okita  et  al.,  2007).  Endoderm  
also  plays  a  role  in  signalling  to  mesoderm  to  form  muscle  in  specific  formations.    
For   the   purposes   of   this   study   the   main   focus   will   be   on   mesodermal   lineage  
specification   and   mesodermal   tissues,   specifically   endothelium.   Mesoderm   is   first  
identified   during   the   formation   of   the   primitive   streak  which   then  migrates   laterally  
and   anteriorly   and   patterns   into   populations   with   specific   developmental   fates  
(Lacaud  et  al.,  2004).  Mesoderm  forms  multiple  different   tissue   types   including   the  
notochord,   skeletal   system,   muscular   system,   dermis   of   skin,   kidney,   blood,  
endothelium  and  cardiovascular  tissue    (Fehling,  2003;;  Lacaud  et  al.,  2004;;  Okita  et  
al.,   2007).   Mesoderm   is   known   to   be   directed   through   controlled   decrease   in  
expression   of   Oct4   but   also   by   specific   genes   such   as   Brachyury,   Twist2,   FoxA2  
and  Mixl1   (Okita   et   al.,   2007;;  Poh  et   al.,   2014).As   it   has   been   shown   that   factors  
such   as   Brachyury   are   markers   of   terminal   fate   determination   towards   a  
mesendodermal   commitment.   Brachyury   has   become   an   important   marker   of  
mesodermal   specification   (Martin  and  Kimelman,  2010;;  Smith  et  al.,   1991).  These  
Brachyury-­expressing   mesodermal   progenitor   cells   are   essential   to   form   the  
different   tissues  mentioned   above   including   endothelium   (Figure   1.5).   These   cells  
mature  to  produce  a  set  of  KDR  expressing  mesodermal  progenitor  cells  which  are  
essential  to  the  formation  of  the  haemangioblast  (Figure  1.5)  (Choi  et  al.,  1998;;  Park  
et   al.,   2013).   The  haemangioblast   then   develops   to   form  haematopoetic   cells   and  
endothelium.   The   haemangioblastic   cells   that   are   destined   to   form   endothelium  
develop   into   specific   endothelial   cells   to   form   the   vascular   and   lymphatic   system  
(Figure  1.5)   (De  Val  and  Black,  2009).  These  subtypes  of  endothelial  cells  can  be  
identified  through  specific  factors  as  mentioned  in  section  1.6.  These  cells  then  form  
the  lining  of  blood  vessels  and  lymphatic  vessels  which  is  known  as  the  endothelium  
(De  Val   and  Black,   2009).  This   is   just   one  example  of   the   tissues   that  mesoderm  








Figure   1.5.   Model   of   Mesodermal   Progenitor   Cell   Differentiation   into  
Endothelial  Cells    
Development  of  arterial,  venous  and  lymphatic  endothelial  cells  from  a  Brachyury-­
expressing  progenitor  cells  via  the  formation  of  the  haemangioblast  which  has  
endothelial  and  haematopoietic  differentiation  potential.  
	  
1.6   In  vitro  Differentiation  Protocols:  
  
Differentiation   protocols   have   been   developed   for  many   years   and   developmental  
pathways   have   been   mimicked   to   produce   multiple   different   cells   types   such   as  
cardiomyocytes,   neural   cells   and   endothelial   cells   (Wang   et   al.,   2011;;   Zwi   et   al.,  
2009).  Many   of   these   protocols   initially   focussed   on   the   directed   differentiation   of  
embryonic   stem   cells   and   many   different   cell   types   were   generated   (Bibel   et   al.,  
2004;;  Xu   et   al.,   2002).  However,   since   the   development   of   iPSCs   the  main   focus  
has   shifted  more   towards   the   differentiation   of   iPSCS   to   generate   patient-­specific  
functional   cells   that   could   be   transplanted   to   regenerate   damaged   tissues.   An  
example   that   is   relevant   to   this   project   is   the   differentiation   protocol   designed   to  
induce   endothelial   cell   differentiation   from   either   embryonic   stem   cells   or   iPSCs.  
Endothelial   cells   and   haematopoietic   cells   are   thought   to   develop   from   the   same  
precursor   cell   known   as   the   the   haemangioblast.   It   is   thought   that   the  
haemangioblast   develops   into   an   endothelial   progenitor   cell   that   is   capable   of  
differentiating  into  an  endothelial  cell  or  a  haematopoietic  cell  (Fehling,  2003;;  Xiong,  




















as   the   endothelium   (Lerman   and   Zeiher,   2005).   The   endothelium   is   a   semi  
permeable  membrane  and  controls  the  transfer  of  small  and   large  molecules.  Both  
endothelial   cells   and   the   endothelium   are   involved   in  multiple   biological   functions.  
Examples   of   these   functions   include   thrombosis   and   thrombolysis,   which   is   the  
creation   and   break   down   of   blood   clots,   and   platelet   adherence   and   regulation   of  
vascular   tone   and   blood   flow   (Verhamme   and   Hoylaerts,   2006).   Finally,   the  
endothelium   is   also   involved   in   the   regulation   of   leukocyte,   monocyte   and  
lymphocyte   interactions   with   the   vessel   wall   which   control   immune   responses  
specifically   inflammation   (Danese   et   al.,   2007).   There   are   also   associated  
pathologies   linked   to  endothelial  cells   that  have  discordant  stimulation  or  a   lack  of  
control   of   endothelial   cell   response.   These   conditions   include   atherosclerosis,  
vasculopathy,   hypertension,   congestive   heart   failure   and   inflammatory   syndromes  
(Rajendran  et  al.,  2013),  which  are  related  to  endothelial  injury  and  dysfunction.    
The   majority   of   endothelial   differentiation   protocols   using   pluripotent   cells   initially  
include  a  step  to  create  a  mesodermal  progenitor  cell  which  is  usually  achieved  by  
exposure  to  specific  growth  conditions.  An  example  of  such  conditions  is  growth  of  
iPSCs   in   a   mesodermal   induction   medium   which   consists   of   DMEM:F12   with  
15mg/ml   stem   cell   grade   bovine   serum   albumin   (BSA),   17.5µg/ml   human   insulin,  
275µg/ml   human   holo-­transferrin,   20ng/ml   FGF-­2,   50ng/ml   human   VEGF-­165,  
25ng/ml   human   BMP4,   450   monothioglycerol   and   2.25mM   each   L-­glutamine   and  
non-­essential   amino   acids   (Kurian   et   al.,   2013).   There   are   multiple   markers   that  
have  been  found  in  early  endothelial  progenitor  cells/angioblast  cells  including  KDR  
and   CD133   (Asahara   et   al.,   1997).   These   are   cells   are   derived   from   the  
haemangioblast  but  have  differentiated  to  an  early  endothelial  progenitor  cell.  When  
these   cells   then   start   to   develop   they   lose   CD133   when   differentiating   into   more  
mature  endothelial  cells  and  they  gain  VE-­cadherin  and  von  Willebrand  factor.  In  the  
study  by  Kurian  et  al,  after  8  days  there  was  a  peak  in  the  CD45+  cell  population  with  
an   increase   in   CD31   and   mesodermal   progenitor   markers   and   downregulation   of  
pluripotency-­related  factors  (Kurian  et  al.,  2013).  It   is  thought  that  these  cells  could  
be  representative  of  a  developmental  stage  similar  to  the  angioblast.  The  cells  were  
tested   for   their   ability   to   differentiate   into   an   endothelial-­like   cell   and   they   showed  
upregulation  of  endothelial  markers  VE-­cadherin,  vWF  and  KDR.  This  process  using  
iPSCS  takes  approximately  24  days  (Kurian  et  al.,  2013).  The  endothelial  cells  were  
tested   for  markers  specific   to  certain  subtypes  of  endothelial   cell.     These   included  
eight   arterial   markers   ALK1,   Nrp-­1,   CXCR4   and   EPHB2,   three   venous   markers  




VEGFR3,   vWF   and   CDH5.   Increased   expression   of   these   markers      was   shown  
(Kurian  et  al.,  2013).  The  cells  were  also  tested  for  their  functionality  by  testing  their  
ability   to   form   capillary   like   structures   when   grown   on   Matrigel   and   their   ac-­LDL  
uptake  (Kurian  et  al.,  2013).  
There  are  variations  between  different  differentiation  media.  The  basic  combination  
that  the  majority  of  differentiation  media  contain  includes  the  use  of  the  supplements  
vascular   endothelial   growth   factor   (VEGF)   and   bone   morphogenetic   protein-­4  
(BMP4)  which  is  added  to  Minimum  Eagle’s  Medium  along  with  the  basic  cell  growth  
supplements:   20%  FBS,   L-­glutamine,   beta-­mercaptoethanol   and  1%  non-­essential  
amino   acids   (Kurian   et   al.,   2013;;  Sayed   et   al.,   2014).   There   are   other  media   that  
contain  other  factors  such  as  insulin-­like  growth  factor  and  TGF-­beta  which  are  also  
thought   to   aid   endothelial   cell   differentiation   (Marcelo   et   al.,   2013).   However,   the  
essential   factors   that   appear   in   most   differentiation   protocols   are   VEGF   at  
approximately   50ng/ml,   FGF-­2   at   approximately   20ng/ml   and   BMP4   where   the  
concentration  varies  considerably  between  different  protocols  (Breier  et  al.,  1992).  
  
1.7   Using  a  3D  in  vitro  culture  model  system  to  dedifferentiate  
Mesenchymal  Stromal  Cells  (MSCs):  
  
Previous  work  in  this  laboratory  has  shown  that  bone  marrow-­derived  mesenchymal  
stromal  cells   (MSCs)  undergo  dedifferentiation   to  an  early  mesendoderm-­like  state  
when  grown  as  3D  spheroids   in  non  adherent  96-­well  U-­bottomed  plates   in  0.25%  
methyl   cellulose   in  DMEM   for   five   days   at   37°C   and   5%  CO2   (Figure   1.6).   It   was  
proposed   that   this   model   of   dedifferentiation   has   very   broad   similarities   to   the  
formation   of   a   blastema;;   the   condensate   of   mesenchymal   cells   from   which   the  
regenerated   tissues   can   arise   and   in   lower   organisms   can   enable   whole   limb  
regeneration  (Tsonis,  1996).  Using  3D  culture  it  was  shown  that  3D  MSCs  have  low  
level  mRNA  expression  of  the  pluripotency  factors  Oct4,  Sox2  and  Nanog  (Pennock  
et   al.,   2015).  When   the   levels  were   compared   to   embryonic   stem   cells   they  were  
considerably   lower   (Pennock  et  al.,   2015a).   In   contrast,   3D  MSCs  expressed  high  
levels   of   CXCR4,   Brachyury,   Goosecoid   Mixl   and   KDR   mRNA   with   widespread  
protein  expression  of  CXCR4,  Brachyury  and  KDR.   (Pennock  et  al.,   2015).  These  
data   show   that   the   cells   cultured   in   3D   are   not   pluripotent   but   may   be   at   an  
equivalent   developmental   stage   to   early   mesoderm   based   on  marker   expression.  




during  development,  such  as  haematopoietic  stem  cells  which  also  develop  from  a  
mesodermal   lineage   (Miller   et   al.,   2008;;   Smith   et   al.,   1991).   Expression   of   both  
Brachyury,  Goosecoid  and  CXCR4  increases  with  initial  differentiation  into  definitive  
mesoderm  but  then  starts  decreasing  when  the  cells  begin  to  mature  further  (Miller  
et  al.,  2008;;  Rettig  et  al.,  2012;;  Takenaga  et  al.,  2007).    
This   previous   work   led   to   the   proposal   that   the   3D-­induced   dedifferentiation  
phenomenon   occurred   at   least   in   part   through   a   controlled   autophagy   response.  
Autophagy   is   the   mechanism   by   which   cells   survive   under   stress   by   removing  
damaged  cellular  contents  such  as  mitochondria,  ER  and  misfolded  proteins  (Glick  
et   al.,   2010).   By   exposing   the   cells   to   3D   culture   it   is   possible   to   optimise   the  
process   of   clearing   damage   from   the   cells   and   enable   rejuvenation   and  
dedifferentiation.   This   was   seen   by   mRNA   expression   of   TFEB   and   upregulated  
protein   expression   of   LAMP-­1   (Pennock   et   al.,   2015).   Transmission   Electron  
Microscopy   (TEMs)   showed   increased   autophagosome-­   and   lysosomal-­like  
structures   which   also   points   towards   an   increase   in   autophagy   (Pennock   et   al.,  
2015).  In  addition,  it  was  demonstrated  that  during  dedifferentiation  in  3D,  the  cells  
switched  from  oxidative  phosphorylation  to  anaerobic-­type  metabolism.  This  type  of  
metabolic   switch   has   been   confirmed   to   occur   in   cells   dedifferentiating   towards  
pluripotency   (Folmes   et   al.,   2011;;   Varum   et   al.,   2011).   Blastemal   cells   have   also  
been  reported  to  switch  to  glycolytic  metabolism  (Gilbert,  2000;;  Tsonis,  1996;;  Varga  
et  al.,  2014)  
3D  MSCs   that   were   transplanted   into   mice   remained   small   and   generated   highly  
organised   defined   mesodermal   structures   including   muscle,   cartilage   and  
connective  tissue  (Pennock  et  al.,  2015).  The  benefits  of  producing  a  cell  that  is  not  
fully   reprogrammed   to   a   pluripotent   state   (unlike   iPSCs)  means   they   do   not   form  
teratomas.  When  placed   in  mice   tissue   they  appear  only   to  be  capable  of   forming  
tissues   of   mesodermal   origin   (Pennock   et   al.,   2015).   This   method   is   efficient,  
synchronous   and   could   potentially   be   adapted   for   cell   types,   such   as   fibroblasts  
which   are   often   the   cell   of   choice   in   iPSC   reprogramming.   The   ability   to  
dedifferentiate   cells   through   modifying   their   growth   environments   also   avoids   the  









Figure  1.6.  Dedifferentiation  of  Mesenchymal  Stromal  Cells  in  3D  Culture.  
Bone  marrow  mesenchymal  stromal  cells   (MSCs)  undergo  dedifferentiation   to  an  early  
mesendoderm-­like   state   when   grown   as   3D   spheroid   cultures   in   a   size-­   and   time-­
dependent   manner.      MSCs   are   grown   in   96-­well   U-­bottomed   plates   in   0.25%  methyl  
cellulose  in  DMEM  for  five  days  at  37°C  and  5%  CO2.  
  
1.8   Project  Aims  
  
It   was   hypothesised   that   adult   human   dermal   fibroblasts   (HDFs)   can   be  
dedifferentiated  using  specific  3D  culture  conditions  and   the  dedifferentiated  HDFs  
can  be  directly  reprogrammed  into  endothelial-­like  cells.  
The  aims  of  this  project  are:  
1.   Determine   whether   adult   HDFs   dedifferentiate   to   an   early   mesoderm-­like  
state  when  cultured  in  3D  conditions.  
2.   Investigate  whether  autophagy  has  a  role  in  the  dedifferentiation  process.  
3.   Investigate   the   capacity   of   the   dedifferentiated   HDFs   to   convert   to  









2   Methods  
	  
2.1   Cell  Culture    
  
2.1.1   HDF  Expansion  Conditions:  
  
Adult   HDFs   were   cultured   in   Dulbecco’s   Modified   Eagle   Medium   (DMEM)  
supplemented   with   10%   foetal   bovine   serum   (FBS)   and   1%   penicillin   and  
streptomycin  (P/S)  at  37°C  in  5%  CO2  atmosphere.  DMEM  and  P/S  were  supplied  by  
Invitrogen   and   FBS   by   Biowhittaker.   HDFs   were   trypsinised   in   1x   trypsin   and  
passaged  at  a  ratio  of  1:2-­  1:4  and  then  placed  into  the  necessary  number  of  flasks.  
HDFs  used  experimentally  were  at  a  variety  of  Passages  (9-­20)  and  were  supplied  
by  Fischer  Scientific  (Cat.  No.  10407693  &  unknown).    
  
2.1.2   HUVEC  expansion  conditions:  
  
HUVECs   (PromoCell   GmbH)   were   cultured   in   Endothelial   Cell   Growth   Medium   1  
(PromoCell,   Cat.   No.   C-­22010)   with   the   endothelial   cell   growth   supplements  
provided  at  37°C  in  5%  CO2  atmosphere.  Flasks  were  coated  with  gelatin  by  adding  
sterile  water  with  0.1%  gelatin  for  five  minutes.  Then  the  excess  water  was  removed  
and   the   flasks  were   left   to   dry   for   one   hour   in   a   class   II   safety   cabinet.   HUVECs  
were  trypsinised  in  1x  trypsin  and  passaged  at  a  ratio  of  1:2-­1:4.  The  cells  were  then  
placed   into   the   necessary   number   of   gelatin   coated   flasks.   HUVECs   used  
experimentally  were  at  Passages  5-­12.  
  
2.1.3   HDF  3D  culture  conditions:  
  
Just   prior   to   confluency  HDFs  were   trypsinised,   counted   using   a   haemocytometer  
and  centrifuged  at  400xg   for   five  minutes.  The  cells  were   then  resuspended   in   the  
correct  amount  of  3D  culture  media  as  described  in  2.1.1.  with  the  addition  of  0.25%  
methyl   cellulose   in  order   to   increase  spheroid   stability.  The  cells  were  placed   in  a  
96-­well   round   bottomed   plates   and   left   to   incubate   at   37°C   with   5%   CO2.   The  
spheroids  were  split-­fed  by  removing  two-­thirds  of  the  3D  media  and  replacing  it  with  





2.1.4   3D  HDF  snap  freezing  and  sectioning:  
  
HDF  spheroids  were   removed   from   the  96-­well   round  bottomed  plates  and  placed  
into   an   Eppendorf   lid.   O.C.T   mounting   medium   was   added   and   the   sample   was  
frozen  in  liquid  nitrogen.  Then  using  a  Bright’s  cryostat,  10µm  sections  were  cut  and  
collected  on  slides  in  preparation  for  immunostaining.  
  
2.2   RNA  Extraction  and  Processing  
	  
2.2.1   Cell  Lysis:  
  
Cells  were  suspended  in  1x  PBS  and  centrifuged  at  400xg  for  5  minutes.  RNA  was  
then   extracted   using   the   Nucleospin   Kit   by   Machinery-­Nagel,   according   to   the  
manufacturer’s   instructions   and   using   the   buffers   provided.   The   cells   were   then  
resuspended   in  350µl   cell   lysis  buffer  RA1,   containing  3.5µl   beta-­mercaptoethanol  
(Sigma,  Cat.  No.  M6250),  and  pipetted  gently.  The   lysate  was   filtrated   through   the  
NucleoSpin  Filter.    
  
2.2.2   RNA  extraction:  
  
Once  the  cells  were  lysed  and  filtered,  the  RNA  was  extracted  following  the  protocol  
from  Macherey-­Nagel  using  the  buffers  provided.  350µl  of  70%  ethanol  was  added  
to   the   filtrate  and  mixed.  The  mixture  containing   the  RNA  was  centrifuged   through  
an  NucleoSpin  RNA  Column  at  11,000xg  for  one  minute  in  order  to  bind  the  RNA.  A  
pre-­DNAse  digestion  step  included  desalting  the  silica  membrane.  This  was  done  by  
adding  350µl  Membrane  Desalting  Buffer   (MBD)   to   the  column  and  centrifuging  at  
11,000xg   for   one  minute.  The  DNA  was  digested  using  10µl   reconstituted   rDNase  
diluted  in  90µl  Reaction  Buffer  for  rDNase.  The  rDNase  was  added  and  incubated  at  
room   temperature   for   15   minutes.   The   silica   membrane   was   then   washed   using  
buffer   RA2   in   order   to   inactivate   the   rDNase.   The   membrane   was   washed   twice  
more  using  buffer  RA3.  The  column  was  then  centrifuged  at  11,000xg  for  one  minute  
in  order  to  assure  the  membrane  no  longer  contained  any  RA3  buffer.    30  µl  RNase-­
free  H2O   provided  was   added   to   the   column   and   centrifuged   at   11,000xg   for   one  




the  bound  RNA.  The  RNase-­free  H2O  was  run  through  the  column  twice  in  order  to  
ensure  elution  of  all  the  bound  RNA.  
2.2.3   CDNA  synthesis:  
  
Using   the   RNA   extracted   using   the   Nucleospin   RNA   Kit,   cDNA   was   synthesised  
using  Oligo  dT  kit   (Invitrogen,  Cat.  No.  18418-­012)   for  PCR.  RNA  was  mixed  with  
1µl  of  Oligo  dt  primer,  1µl  of  10mM  dNTPs  and  made  up  to  12µl  using  H2O.  Samples  
were   mixed   using   a   picofuge   then   incubated   at   65ºC   for   five   minutes,   and   then  
chilled   for   two  minutes  and  microfuged  to  collect   the  contents.  7µl  of  a  master  mix  
(4µl  1st  Strand  buffer,  2  µl  0.1M  DTT  and  1µl  H2O)  was  added   to   the  sample  and  
incubated  at  42ºC  for  two  minutes.  1µl  of  Superscript  II  was  added  to  samples  with  
the  exception  of  a   control  without   reverse   transcriptase.  Samples  were  mixed  and  
incubated  at  42ºC  for  one  hour  in  order  to  have  the  reverse  transcriptase  at  optimal  
conditions.  The  reverse  transcriptase  was  then  inactivated  by  incubating  the  sample  
at  70ºC  for  15  minutes.  
  
2.2.4   Quantitative  real-­time  PCR:  
  
The  cDNA  was  used  for  quantitative  real-­time  PCR  (QPCR)  in  96-­well  plates.  Each  
well   contained   17µl   of   a  master  mix,  which   consisted   of   10µl   SybrGreen   (Applied  
Biosystems,   Cat.   No.   10459604),   5.5µl   H2O   and   1.5µl   primer   of   interest   (50%  
forward,  50%  reverse).  3µl  of  cDNA  was  then  added  to  each  well  and  the  plate  was  
centrifuged.   The   QPCR   plate   was   then   read   using   StepOnePlus   Real   Time   PCR  
System.   The   general   housekeeping   gene   used   for   all   QPCR   done   was   GAPDH  
(Table  1).  Controls  for  all  QPCR  include  testing  each  mastermix  with  3µl  of  H2O  and  
the  no-­reverse  transcriptase  control  in  GAPDH  mastermix.  Primers  for  VE-­Cadherin,  
Nrp-­1,   Nrp-­2,   ALK1   and   EPHB4   sequences   were   published   previously   (Table   1)  










Gene   Forward   Primer  
Sequence  (5’-­3’)  
Reverse   Primer   Sequence  
(3’-­5’)  
GenBank  







Oct4   CCCACACTGCAGATCAG   GGGTGTGACGTCTAGTC   NM_002701  
Sox2   GAGAACCCCAAGATGCAC
AAC  
CGCTTAGCCTCGTCGATGA   NM_003106  
Nanog   CCTCCATGGATCTGCTTAT
TCAG  
CGCTTAGCCTCGTCGATGA   NM_024865  
Brachyury   GGGTCCACAGCGCARGAT   TGATAAGCAGTCACCGCTATG   NM_003181  
Goosecoid   GATGCTGCCCTACATGAAC
GT  
CTACGACGGGATGTACTTG   NM_173849  














CCACGCGCCAAGAGGCTTA   NM_002253  
VE-­Cadherin   GACCGGGAGAATATCTCA
GAGT  






















Kurian   et   al.  
2013  
  




2.3   Protein-­based  analyses  
  
2.3.1     Protein  Extraction:  
  
Samples  were  prepared  either  through  trypsinisation  or  disaggregation  and  washed  
twice   in   1x   PBS.   The   samples   were   then   resuspended   in   RIPA   buffer   (Thermo  
Scientific)   containing   0.5%   protease   inhibitor   cocktail   set   III   (Calbiochem)   and  
100µM  Na3VO4   (Sigma).  The   sample  was   then   frozen   at   -­80ºC   until   needed.  The  
samples   were   centrifuged   at   14,000xg   for   10   minutes   at   4ºC   to   separate   the  
insoluble  fraction  from  the  sample.  Supernatant  containing  the  soluble  fraction  was  
then   transferred   to   a   fresh  Eppendorf.   Protein   quantification  was   performed   using  
the   BCA   protein   Assay   Kit   (Thermo   Scientific).   The   protein   concentrations   were  
calculated   from   a   standard   curve   generated   from   standard   samples   of   known  
concentration  using  absorbance  measurements  at  570nm.  
  
2.3.2   Western  Blot  Analysis:  
  
Protein  samples  were  prepared  for  western  blotting  by  mixing  samples  of  20µg/well  
protein   quantity   3:1   with   4X   loading   buffer   and   heated   to   95°C   for   5   minutes.  
Samples  were  loaded  into  a  10%  acrylamide  gel  and  electrophoresed  at  130V  for  90  
minutes.   Proteins   were   then   wet-­transferred   onto   a   nitrocellulose   membrane.  
Primary   antibodies   against   LAMP-­1   and   CXCR4   (Table   2)   were   diluted   in   Tris-­
Buffered  Saline  and  Tween20  (TBS-­T)  plus  4%  Marvel  and  left  to  incubate  in  a  heat  
sealed   bag   whilst   rotating   overnight   at   4°C.   Following   washing   in   TBS-­T   HRP-­
labelled   (horse   radish   peroxidase)   secondary   antibodies   were   added   and   left   to  
incubate  for  one  hour  at  room  temperature.  Membranes  were  prepared  for  imaging  
using   Enhanced   ChemiLuminescence   (ECL)   reagents   (Promega)   following   the  
manufacturer’s   instructions   and   images   were   taken   using   the   Genescan   software  










Antibody   Host   Dilution  
(Western  blot)  
Supplier   Cat.  No.  
CXCR4   Rabbit   1:1000   Millipore   AB1846  

















Swine   1:2000   Dako   P0399  
  
Table  2.2.  List  of  Antibodies  Used  for  Western  Blotting  and  Immunostaining  
  
2.4   Immunocytochemistry:  
  
Spheroids   were   sectioned   (see   section   2.1.4.)   and   then   fixed   using   4%  
paraformaldehyde  for  10mins  at  room  temperature.  The  sections  were  then  washed  
using  1x  PBS  and  blocked  with  a  blocking  buffer  (1x  PBS  and  10%  sheep  serum).  
The   blocking   buffer   was   drained   off   and   the   sections   were   incubated   with   Anti-­
CXCR4   (1:100   dilution)   overnight   at   4°C   in   a   humidified   container.   Samples  were  
washed   three   times   for  5  minutes   in  1x  PBS   then   incubated  with  sheep  anti-­rabbit  
IgG-­Cy3   (1:400   dilution)   for   1   hour.   The   washing   step   was   repeated   and   the  
samples  were  mounted   using  Vectashield  mounting  medium   containing  DAPI   and  
imaged   by   confocal  microscopy.   Controls   included   an   isotype   control,   where   non-­
immune   rabbit   IgG   was   used   in   the   place   of   the   anti-­CXCR4   and   a   PBS-­control  





2.5   Transmission  Electron  Microscopy  (TEM):  
  
2D  and  3D  HDFs  were  collected   in  Eppendorf   tubes  and  prepared   for  TEM  by   the  
Biology   Technology   Facility.   They   were   fixed   in   8%   formaldehyde,   5%  
glutaraldehyde  in  100mM  phosphate  buffer  mixed  50/50  with  3D  HDF  medium  for  10  
minutes   followed   by   fixing  with   4%   formaldehyde,   2.5%   glutaraldehyde   in   100mM  
phosphate   buffer,   pH7.2   for   30  minutes   at   room   temperature.   Samples  were   then  
washed   in  100mM  phosphate  buffer,  2  x  20  minutes.  Once   fixation  was  complete,  
the   samples  were   chilled   on   ice   for   60  minutes   in   1%  OsO4   in   100mM   and   then  
washed   in   100mM   phosphate   buffer   for   2   x   10   minutes.   The   sample   was   then  
dehydrated  in  25%,  50%,  70%,  and  90%  ethanol  for  20  minutes,  respectively  with  a  
final   incubation   in  100%  ethanol  2  x  20  minutes  at   room  temperature.  The  sample  
was   then   incubated   in   epoxy   propane   for   15   minutes.   Finally,   the   sample   was  
incubated   3   times   for   30   minutes   in   3   different   ratios   of   epon   araldite   to   epoxy  
propane  at  room  temperature.  (25%  epon  araldite  &  75%  epoxy  propane,  50%  epon  
araldite  &  50  %  epoxy  propane,  75%  epon  araldite  &  25%  epoxy  propane)  with  one  
final  incubation  in  100%  epon  araldite  before  the  samples  are  ready  to  be  sectioned.  
Polymerised   sample   blocks   were   then   sectioned   at   70nm   using   a   Leica   RM2165  
rotary  microtome  and  imaged  on  a  FEI  Tecnai  G  transmission  electron  microscope.  
	  
2.6   Disaggregation  of  spheroids:  
  
The  spheroids  were  removed  from  the  96-­well  plate  and  centrifuged  at  1200rpm  for  
five  minutes  at  4ºC  to  remove  the  3D  culture  media.  The  spheroids  were  washed  in  
5ml   1x  PBS   and   centrifuged.  The   spheroids  were   then   resuspended   in   1x   trypsin  
and  incubated  at  37  ºC  for  five  minutes  and  disaggregated  by  gently  pipetting  for  no  
longer   than  15  minutes.  Serum-­containing  cell  culture  was  added  to  deactivate   the  
trypsin  and  the  cells  collected  by  centrifugation.  
	  
2.7   Network-­forming  Assay:  
  
The   network-­forming   assay   was   performed   using   Matrigel   (Corning,   Product  
Number   354234)   and   endothelial   cell   growth   media   (PromoCell).   Matrigel   was  
thawed  on   ice   to   prevent   it   from  prematurely   polymerising.  Once   the  Matrigel   had  




µl   of   the   mix   was   added   to   the   individual   wells   of   a   24-­well   tissue   culture   plate,  
making  sure  the  gel  was  evenly  distributed.  The  plate  was  then  incubated  at  37  ºC  
for  30  minutes   to  allow  polymerisation.  Cells  were  disaggregated  (see  section  2.6)  
and   washed   in   serum-­containing  medium   then   resuspended   at   500,000   cell/ml   in  
complete  endothelial  cell  growth  media  (EGM)  1-­2  (Promocell,  Cat.  No.  C-­22010  &  
C-­22011)  and  EGM  3-­5  are  made  up  of  EGM2  with  either  VEGF  (R  &  D  Systems,  
Cat.  No.  293-­VE),  BMP4  (Peprotech,  Cat.  No.  120-­05-­5)  or  a  combination  of  both.  
Each  culture  well  had  1ml  of  cell  suspension  added  to  it  and  was  incubated  at  37  ºC  
in  5%  CO2.  Network-­images  were  taken  using  a  Leica  DC  500  microscope  using  the  
LCM  and  brightfield  filters.  
  









0.02ml/ml   0.02ml/ml   0.02ml/ml   0.02ml/ml   0.02ml/ml  
EGM  Suppl.   0.004ml/ml              
EGF   0.1ng/ml   5ng/ml   5ng/ml   5ng/ml   5ng/ml  
FGF-­2   1ng/ml   10ng/ml   10ng/ml   10ng/ml   10ng/ml  
IGF-­165      20ng/ml   20ng/ml   20ng/ml   20ng/ml  
VEGF-­165      0.5ng/ml   50ng/ml   0.5ng/ml   50ng/ml  
Ascorbic  Acid      1µg/ml   1µg/ml   1µg/ml   1µg/ml  
Heparin   90µg/ml   22.5µg/ml   22.5µg/ml   22.5µg/ml   22.5µg/ml  
Hydrocortisone   1µg/ml   0.2µg/ml   0.2µg/ml   0.2µg/ml   0.2µg/ml  
BMP4            5ng/ml   5ng/ml  
	  








2.8   Rhodamine-­Phalloidin  Staining:    
  
HDFs  were  washed   in  1%  PBS  and   then   fixed  using  4%  paraformaldehyde   for  10  
minutes.  HDFs  were  permeabilized  with  0.15%  Triton  X-­100   for  30  minutes  before  
adding   rhodamine-­phalloidin   (ThermoFisher,   Cat.   No.   A22287)   at   a   dilution   of  
1:1000  and  incubated  for  1.5  hours  in  the  dark  to  label  the  actin  cytoskeleton.  HDFs  
were  then  washed  using  1x  PBS  and  the  cells  were   imaged  in  the  cell  culture  well  
and  viewed  using  a  multiphoton  microscope  (Zeiss  LSM  780).  
  
2.9     AcLDL  Uptake:  
  
3D  HDFs  were  disaggregated  (see  section  2.6)  and  grown  on  Matrigel  in  EGM  1  as  
described   in   section   2.7.  Once   the   cells   had   formed   networks   acLDL   uptake  was  
observed  using  50µl   of  Dil-­acLDL   (Biomedical  Technologies   Inc,  Cat.  No.  BT-­902)  
was  added  to  200µl  of  EC  Media  1  and  incubated  at  37  ºC  in  5%  CO2  for  five  hours.  
The   cells   were   then   washed   in   1ml   of   1X   PBS   three   times   and   imaged   using   a  
















3   Results  
  
3.1   Spheroid  Condensation:  
  
Mechanical   stimuli   and   cell   interactions   have   been   shown   to   be   essential   for   the  
development  of  a   fully   formed  embryo.  There  are  multiple  examples  of  mechanical  
stimuli  that  play  a  role  in  cell  lineage  commitment  during  the  development  of  certain  
tissues.  A   few  examples  of  mechanical  stimuli  and   its  effects  are  osmotic  pressure  
altering   egg   cells   as   they   travel   to   the   uterus   or   shear   stress   such   as   the   heart  
pumping   blood  which   plays   a   role   in   endothelial   cell   and   haematopoietic   cell   fate  
determination  (Horner  and  Wolfner,  2008;;  Mammoto  and  Ingber,  2010;;  North  et  al.,  
2009).   Alternatively   spheroid-­like   structures   have   been   seen   in   other   natural  
processes   such   as   in   the   formation   of   the   blastema.   The   blastema   is   found   in  
embryonic   development   and   during   limb   regeneration   in   lower   organisms.   This  
suggests  that  cell  aggregation  and  mechanical  stimulation  are  important  processes  
for  development  and  regeneration  and  possibly  dedifferentiation.  
In  previous  experiments  MSCs  were  shown  to  condense  when  grown  in  3D   in  vitro  
culture   conditions,   which   was   thought   to   be   mimicking   the   developmental   stage  
where  MSCs   form  a  cell   condensate.  This   is  a  very  early  and  critical  stage  during  
the   formation   of   various   organs   including   cartilage,   bone,   muscle   and   more.   The  
cells  gather  in  order  to  differentiate  into  different  cell  types.  There  are  many  factors  
that   control   mesenchymal   condensation   formation   including   changes   in   cell  
proliferation  and  reorganisation  of   the  extracellular  matrix   (Frenz  et  al.,  1989).  The  
mechanism  in  which  mesenchymal  condensation  controls  cell  fate  has  not  been  fully  
elucidated.   However,   because   mechanical   stimuli   are   known   to   play   a   role   in  
development  and  cell   specification,   it   suggests   that   the  mechanical   forces  created  
during  mesenchymal  condensation  could  be  playing  a  role  in  differentiation  and  cell  
fate   determination.   Alternatively,   the   formation   of   this   mass   of   cells   could   be  
mimicking   the   blastemal   characteristics   as   the   results   that   show  broad   similarities  
between  the  3D  culture  system  and  blastema  formation.    
Using   the   same   growth   conditions   as   those   used   to   generate   3D  MSCs   (section  
2.1.3.)   it   was   determined   whether   HDFs   similarly   underwent   3D-­induced  
condensation.  
Spheroids   containing   30,000   HDFs   and   60,000   HDFs   were   made   and   the   size  




spheroids  were  taken  on  days  one  to  five  to  monitor  size  change  over  time.  Images  
show   that   there   is   a   visual   size   decrease  and   the  main   size   change   can  be   seen  
between   days   one   to   three   (Figure   3.1a).   The   spheroids   were   measured   using  
ImageJ  and  a  graph  was  plotted  of  the  size  change  in  µm  (Figure  3.1b).  The  largest  
size  change  of  190µm  was  measured  between  days  one  to  three.  Once  day  three  of  
3D   culture   was   reached,   the   size   appeared   to   be   maintained   or   decreased   very  
slightly.  In  order  to  visualise  this  pattern,  a  graph  of  the  percentage  change  was  also  
plotted  (Figure  3.1c).  The  graph  of  the  percentage  change  shows  a  steep  reduction  
in   size   between   days   one   to   three   and   then   a   clear   plateau   at   day   three   for   both  
30,000  and  60,000  spheroids.  The  60,000  HDF  spheroids  show  a  clear  plateau   in  
respect   to   size   change   and   the   size  measured   at   day   three   is  maintained   on   the  
following   days   whereas   the   30,000   HDF   spheroids   continued   to   condense   and  
decrease   in   size   at   a   much   slower   rate.   This   suggests   that   the   HDFs   are   also  
condensing   to   form   these  3D  aggregates  or  blastemal-­like  structures  similar   to   the  
MSCs  that  were  grown  in  3D  culture  (Pennock  et  al.,  2015).    
Additionally,  spheroids  were  sectioned  and  stained  with  toluidene  blue  and  imaged  
in   order   to   determine   changes   in   the   internal   organisation   of   the   spheroid   (Figure  
3.2a).   The   micrographs   show   that   there   is   a   fairly   even   distribution   of   cells  
throughout   the   spheroid.   However,   there   also   appears   to   be   a   slightly   more   cell  
dense  area  towards  the  centre  of  the  spheroid  with  fewer  cells  towards  the  outside  





Figure  3.1.  Condensation  of  HDF  Spheroids  in  3D  in  vitro  Culture  Conditions.  
Decrease   in   diameter   of   the   HDFs   when   cultured   in   3D.   a)   Brightfield   images   of   the  
spheroids  (sizes  30,000  and  60,000)  from  which  diameters  were  measured.  b)  Graph  of  
the  mean  size  decrease  (µm)  of  six  spheroids  over  a  five  day  period  ±  SEM.  c)  Graph  of  










































Figure  3.2.  Toluidene  Blue  Staining  of  3D  HDF  Spheroid  Sections.  
HDFs   were   grown   as   30,000   HDF   spheroids   for   four   days   fixed   and   sectioned   (see  
sections  2.1.3.  &  2.5)   then  stained  with   toluidene  blue.  a)  Whole  section   image   (scale  
bar  =  100µm).  b)  Centre  of  the  spheroid  (scale  bar  =  50µm).  c)  Edge  of  spheroid  (scale  




3.2   Determining  the  Optimal  Spheroid  Size  and  Culture  Time:  
  
The  HDFs  were  initially  tested  to  determine  whether  they  would  also  dedifferentiate  
in   3D   growth   conditions,   similar   to   that   of   3D  MSCs.  This  was   confirmed   through  
QPCR  of  pluripotency  factors  Oct4,  Sox2  and  Nanog.  All  three  of  these  factors  are  
absent   from   fully   differentiated   adult   cells   meaning   upregulated   expression   would  
suggest  dedifferentiation  is  occurring  (Masui  et  al.,  2007).    
3D   HDFS   from   two   different   donors   were   grown   as   30,000   and   60,000   HDF  
spheroids  and  cultured  for  up  to  five  days  (see  section  2.1.3.).  The  highest  size  and  
time-­dependent  increase  in  expression  of  pluripotency  factors  was  used  in  order  to  
decide   the   optimal   3D   culture   conditions   for   HDFs.   RNA   was   extracted   from  
spheroids  on  days  three  to  five  and  processed  using  methods  described  in  section  
2.2.   The   expression   of   Sox2,   Oct4,   Nanog   was   determined   using   QPCR   (Figure  
3.3).  Oct4  expression  levels  increased  in  both  the  30,000  and  60,000  HDF  spheroid  
sizes  over   the   five  day  3D  culture  period.  By  day   three   the  expression   levels   had  
increased  6-­fold   for  30,000  HDF  spheroids  and  12-­fold   for  60,000  spheroids.  Both  
spheroid   sizes   maintained   higher   but   varying   expression   levels   of   Oct4   than   the  
HDFs  grown   in   standard  2D  monolayer   conditions   (Figure  3.3a).  The  60,000  HDF  
spheroids  increased  to  approximately  16-­fold  by  day  five.  However,  the  highest  fold  
change  was  seen  in  the  30,000  HDF  spheroids  at  day  four  with  an  18-­fold  increase  
in   Oct4   expression   (Figure   3.3a).   The   same   samples   were   also   tested   for   Sox2  
expression.   Similarly,   to   Oct4   expression   both   the   30,000   and   60,000   HDF  
spheroids   had   increased   Sox2   expression   by   day   three,   with   much   higher   fold  
changes   (13-­fold   increase  and  a  27-­fold   increase,   respectively)   compared   to  Oct4  
(Figure  3.3b).  The  expression  levels  of  Sox2  for  both  spheroid  sizes  varied  but  also  
remained  higher  than  HDFs  grown  in  standard  2D  conditions  throughout  the  time  in  
culture.   Once   again   the   highest   fold-­change   was   seen   on   day   four   in   the   30,000  
HDF   spheroids   with   a   fold   change   of   approximately   42,   whereas   the   highest   fold  
change   for   the   60,000   HDF   spheroids   was   the   day   three   27-­fold   change   (Figure  
3.3b).  Finally,  Nanog  expression  also   increased   in  3D  culture  by  day   three   to  a  9-­
fold   increase   in   30,000   HDF   spheroids   and   11-­fold   increase   in   60,000   HDF  
spheroids  and  despite  variation  also  remained  above  the  2D  HDF  expression  levels  
(Figure   3.3c).   The   largest   fold   change   was   a   24-­fold   change   observed   in   30,000  
HDF  spheroids  on  day  four  similar  to  the  expression  levels  of  Oct4  and  Sox2  and  a  
25-­fold   increase   in   60,000   HDF   spheroids   on   day   five   (Figure   3.3c).   From   these  




HDFs  at  day  four  of  culture.  Oct4  and  Sox2  expression  peaked  at  this  size  and  time  
and   the   expression   of   Nanog   was   also   high.   60,000   HDF   spheroids   on   day   five  
displayed   the  highest   fold  change   for  Nanog.  However,   this  size  and   time  was  not  









Figure  3.3.  QPCR  Analysis  of  Change  in  Expression  of  Oct4,  Sox2  and  Nanog  
in  3D  HDFs  Over  Time.  
HDFs  were  cultured  as  2D  monolayers  and  3D  spheroids  with  initiating  cell  numbers  of  
30,000  and  60,000  cells  for  up  to  five  days  in  culture.  RNA  was  extracted  from  2D  HDFs  
at   80%   confluency   on   day   one   and   from   120   spheroids   on   days   three-­five.   cDNA  
samples  were  generated  and   then  analysed  by  QPCR.  Expression  of  Oct4,  Sox2  and  
Nanog  for  was  normalised  to  expression  of  the  housekeeping  gene  GAPDH  and  made  
relative   to  expression   levels   the  2D  sample.  Fold  changes  were  calculated  as  2-­ddCt.  
Data   from   two   HDF   cell   lines   identified   in   section   2.1.1.   were   pooled   and   mean   fold  




























































3.3   Expression  of  Mesodermal  Markers:  
  
The   expression   levels   of   pluripotency   factors   in   MSCs   are   not   as   high   as   in  
pluripotent  stem  cells  (Pennock  et  al.,  2015)  and  the  3D  MSCs  have  been  identified  
as  mesoderm   specific   through   the   expression   of  mesodermal  markers   Brachyury,  
Goosecoid,   KDR,   CXCR4   and   a   decrease   in   CXCL12.   Due   to   these   findings   the  
HDFs  were  also  analysed  for  the  expression  of  markers  associated  with  early  germ  
layer   specification.   Two   separate   samples   of   HDFs   from   different   donors   were  
cultured  as  monolayers  and  as  30,000  HDF  spheroids  for  up  to  five  days.  RNA  was  
extracted   on   days   three   to   five.   This   RNA   was   then   processed   as   explained   in  
section  2.2  and  analysed  through  QPCR  was  used  to  analyse  the  expression  levels  
of  Brachyury,  Goosecoid,  KDR,  CXCR4  and  CXCL12  in  3D  HDFs  compared  to  2D  
HDFs.  
  
Brachyury   is   a   highly   conserved   gene   and   transcripts   first   appear   during  
development  at  the  mid-­blastula  transition  and  the  highest  expression  occurs  during  
gastrulation   and   this   is   necessary   for   mesoderm   formation   (Artinger   et   al.,   1997;;  
Smith   et   al.,   1991).   Brachyury   is   known   to   have   an   important   role   in   the  
development  of  various  tissue  types,  an  example  of  which  is  vertebrate  development  
through  a  Brachyury  and  canonical  Wnt  signalling  loop  and  as  previously  mentioned  
a   lack   of   Brachyury   expression   results   in   a   truncated   body   axis   (Martin   and  
Kimelman,  2010).  The  expression  of  Brachyury  decreases  afterwards.  This  makes  
Brachyury   an   early   marker   for   mesoderm   formation.   The   QPCR   results   for  
Brachyury   showed   that   by   day   three   there   was   a   2.5-­fold   increase   in   expression  
when  compared  to  2D  HDFs.  By  day  four  there  was  a  further  increase  of  up  to  5.5-­
fold  which  then  continued  to  decrease  on  day  5  to  approximately  a  4.5-­fold  change  
(Figure  3.4a).  The  expression  change  of  most  significance   is  day   four  as   this  was  
the  day  chosen  to  be  the  optimal  size  and  time  for  dedifferentiation  as  supported  by  
the   data   on   pluripotency   factor   expression.   Goosecoid   is   a   homeobox-­containing  
gene   that   is   expressed   during   gastrulation   and   is   thought   to   be   involved   in   the  
Spemann’s   organiser   (Artinger   et   al.,   1997;;   Cho   et   al.,   1991).   Expression   levels  
decrease   during   differentiation   which  means   it   can   also   be   used   as   a  marker   for  
mesoderm   formation.   The   QPCR   results   for   Goosecoid   showed   an   increase   in  
expression  in  3D  compared  to  2D  HDFs  with  a  14-­fold  increase  by  day  three  which  
continued  to  increase  on  day  four  up  to  27-­fold  increase.  The  expression  levels  then  
dropped  to  a  21-­fold   increase  on  day  five  (Figure  3.4b).  This  pattern  of   increase  in  




pattern  that  Brachyury  expression  levels  follow  but  the  fold  change  for  Goosecoid  is  
considerably  higher  (figure  3.4b).  Kinase  insert  domain  receptor  (KDR)  also  known  
as   vascular   endothelial   growth   factor   receptor  2   (VEGFR2)   is   found   in  multipotent  
mesodermal  progenitor  cell.  These  KDR  expressing  progenitor  cells  are  essential  to  
the   formation   of   the   haemangioblast   (Shalaby   et   al.,   1995).   KDR   expression  
increases   in   3D   HDFs   in   comparison   to   2D   HDFs   by   approximately   36-­fold.   The  
expression  levels  then  continue  to  increase  to  63-­fold  change  on  day  four  and  then  
drops  to  a  20-­fold  change  on  day  five.  Expression  of  KDR  was  considerably  higher  
than  both  Brachyury  and  Goosecoid,  but  follows  the  same  temporal  pattern  (Figure  
3.4c).   The  mesodermal  marker   expression   data   supports   day   four   as   the   optimal  




















Figure  3.4.  QPCR  Analysis  of  Change  in  Expression  of  Brachyury,  Goosecoid  
and  KDR  in  3D  HDFs  Over  Time.  
HDFs  were  cultured  as  2D  monolayers  and  3D  spheroids  with  initiating  cell  numbers  of  
30,000   cells   for   up   to   five   days   in   culture.  RNA  was  extracted   from  2D  HDFs  at   80%  
confluency  on  day  one  and  from  120  spheroids  on  days  three-­five.  cDNA  samples  were  
generated  and  then  analysed  by  qPCR.  Expression  of  Brachyury,  Goosecoid  and  KDR  
for  was  normalised  to  expression  of  the  housekeeping  gene  GAPDH  and  made  relative  
to  expression  levels  the  2D  sample.  Fold  changes  were  calculated  as  2-­ddCt.  Data  from  
two  HDF  cell   lines   identified   in  section  2.1.1.  were  pooled  and  mean   fold  changes  are  

























































C-­X-­C  chemokine  receptor  4  (CXCR4)  is  expressed  in  cells  during  development  and  
it   binds   to   the   corresponding   ligand   CXCL12   (Sugiyama   et   al.,   2006).   It   has  
fundamental   roles   during   organogenesis   and   is   expressed   during   development   in  
mesoderm   and   definitive   endoderm   but   not   in   ectoderm.   CXCR4   is   involved   in  
dynamic   and   complementary   expression   patterns   in   mesendodermal   specification  
such   as   the   development   of   neuronal,   cardiac,   vascular,   haematopoetic   and  
craniofacial   tissues   (McGrath   et   al.,   1999).   CXCR4   is   also   expressed   by  
haematopoietic  stem  cells  and  is  involved  in  mediating  homing  and  it  is  also  found  in  
endothelium.   Specifically   it   is   often   used   as   a   marker   of   arterial   endothelial   cell  
differentiation  (Kurian  et  al.,  2013;;  McGrath  et  al.,  1999;;  Sugiyama  et  al.,  2006).    
  
CXCR4  decreases  during  differentiation  and  specification  during  development  which  
allows   us   to   use   CXCR4   expression   as   a   method   of   characterising   the  
dedifferentiated  state  of  HDFs  that  have  been  cultured  in  3D.  The  pattern  of  CXCR4  
expression  does  not  appear  to  follow  a  similar  pattern  to  Brachyury  and  Goosecoid.    
CXCR4  expression  greatly  increases  to  approximately  1180-­fold  by  day  three  which  
is  maintained  at  that  level  until  day  five  where  the  expression  level  drops  to  around  a  
210-­fold   increase   (Figure  3.5a).  Additionally,   the  corresponding   ligand   for  CXCR4.  
CXCL12,  which  is  typically  expressed  by  stromal  cells,  was  found  to  decrease  or  be  
maintained  at  2D  levels.  There  was  a  0.6-­fold  decrease  in  expression  by  day  three  
which  went  up  to  0.9-­  and  1.1-­fold  on  days  four  and  five  respectively  (figure  3.5b).  
CXCR4   protein   was   also   detected   throughout   the   3D   HDF   structure   using  
immunostaining  and  by  western  blotting  (Figure  3.6  &  3.7).  Immunostaining  showed  
a   uniform   CXCR4   expression   on   the   surface   of   the   cells   throughout   the   section  
(Figure   3.6).   This   suggests   that   the   cells   spanning   from   the   centre   to   the   outside  
layers  are   relatively  homogenous.  Western  blot  analysis  also  showed   that  CXCR4  
expression   increased   in   the   3D   HDFs   compared   to   the   2D   HDFs   (Figure   3.7).  
Densitometry  using  Image  J  and  this  showed  that  the  intensity  of  CXCR4  expression  












Figure  3.5.  QPCR  Analysis  of  Change  in  Expression  of  CXCR4  in  3D  HDFs  
Over  Time.  
HDFs  were  cultured  as  2D  monolayers  and  3D  spheroids  with  initiating  cell  numbers  of  
30,000   cells   for   up   to   five   days   in   culture.  RNA  was  extracted   from  2D  HDFs  at   80%  
confluency  on  day  one  and  from  120  spheroids  on  days  three-­five.  cDNA  samples  were  
generated  and   then  analysed  by  QPCR.  Expression   of  CXCR4   for  was  normalised   to  
expression  of   the  housekeeping  gene  GAPDH  and  made   relative   to  expression   levels  
the   2D   sample.   Fold   changes   were   calculated   as   2-­ddCt.   Data   from   two   HDF   cell  















































Figure  3.6.  Immunostaining  of  CXCR4  of  3D  HDF  Sections.  
CXCR4   immunostained  sections  of  3D  HDFs  (30,000  cells  per  spheroid,  day   four)   (a).  
Each  sample  shows  DAPI  staining,  CXCR4  staining  and  a  merged  image.  Two  controls  













Figure  3.7.  Western  Blot  Analysis  of  CXCR4  Expression  in  2D  and  3D  HDFs  
using  β-­tubulin  as  a  Control.  
HDFs  were  cultured  as  monolayers  and  as  30,000  HDF  spheroids   for   four  days.  Total  
protein   was   extracted   and   analysed   by   western   blot   analysis.   The   membrane   was  
probed  using  anti-­CXCR4  and  anti-­  β-­tubulin.  The  density  was  measured  using  ImageJ  
3D  expression  levels  were  measured  relative  to  2D  and  then  normalised  to  β-­tubulin.  b)  

























3.4   Analysis  of  Autophagy  in  3D  HDFs:  
  
It  was  hypothesised  that  autophagy  could  play  a  role  in  the  3D  HDF  dedifferentiation  
process  in  a  manner  similar  to  3D  MSCs  (Pennock  et  al,  2015)  due  to  the  apparent  
need  for  cell  size  shrinkage  and  cytoplasmic  remodelling.  An  increased  autophagic  
response   may   also   promote   cytoplasmic   clearance   and   restructuring   required   for  
dedifferentiation  to  a  more  primitive  state.    
  
The  transcription  factor  EB  (TFEB)  is  a  master  gene  linked  to  lysosomal  biogenesis  
and  plays  a  major  role  in  expression  of  autophagy  and  lysosomal  genes  (Settembre  
et   al.,   2011).   HDFs   were   cultured   as   monolayers   and   in   3D   culture   for   up   to   six  
days.  RNA  samples  were  isolated  on  days  three  to  five  and  analysed  using  QPCR  
to   monitor   TFEB   expression   levels   over   time   as   described   in   section   2.2.   It   was  
shown  by  the  third  day  that  a  4-­fold  change  in  TFEB  upregulation  was  observed  in  
3D  HDFs   compared   to   2D  HDFs.   TFEB   expression   continued   to   increase   on   day  
four  with  approximately  a  5-­fold  higher  levels  than  2D  HDFs  (Figure  3.8).  There  was  
a  small  decrease  in  TFEB  expression  on  day  five  at  around  3.5  fold  higher  than  2D  
HDFs.  These  data  would  suggest   that   there   is  an   increase   in  autophagy   in   the  3D  
HDFs.    
  
Lysosomal-­associated   membrane   protein   1   (LAMP-­1)   is   a   lysosomal   glycoprotein  
found  on  the  surface  of  lysosomes  is  thought  to  be  partly  responsible  in  maintaining  
their   integrity   (Jw   et   al.,   1985).   Lysosomes   are   a   key   organelle   in   the   autophagy  
response   as   they   contain   multiple   degradative   enzymes   that   are   used   to   digest  
materials   to   be   cleared   from   the   cell   (Eskelinen,   2006).   Lysosomes   fuse   with  
phagosomes,   to   aid   clearance   of   unwanted   cellular   material,   by   digesting   the  
phagosomal   contents.   HDFs   were   cultured   as   monolayers   and   as   30,000   HDF  
spheroids   for   four   days.   Protein   was   extracted   and   then   analysed   for   LAMP-­1  
expression  by  western  blotting  using  beta-­tubulin  as  a   loading  control   (Figure  3.9).  
3D  HDFs  showed  LAMP-­1  protein  expression  which  when  measured  using  ImageJ  
showed  a  10-­fold   increase   in   intensity   in   the  3D  HDFs  when   compared   to   the  2D  
HDFs  (figure  3.9b).  
    
3D  HDFs  were  also  examined  at  the  ultrastructural  level  for  evidence  of  cytoplasmic  
remodelling.   HDFs   were   grown   as  monolayers   and   as   30,000   HDF   spheroids   for  
four  days  and  then  processed  and  sectioned  as  described  in  section  2.1.3.  The  3D  




images  from  the  TEM  series  showed  numerous  autophagosome-­  and  lysosome-­like  
structures  (Figure  3.10).  The  TEMs  also  showed  mitochondria   that  were  small  and  
rounded  which  would  suggest  mitochondrial   regression.  This  may   indicate   that   the  
3D  HDFs  are  dedifferentiating  and  potentially  switching   from  oxidative   to  glycolytic  









Figure  3.8.  QPCR  Analysis  of  Change  in  Expression  of  TFEB  in  3D  HDFs  Over  
Time  
HDFs  were  cultured  as  2D  monolayers  and  3D  spheroids  with  initiating  cell  numbers  of  
30,000  cells   for  up   to   five  days   in  culture.     RNA  was  extracted   from  2D  HDFs  at  80%  
confluency  on  day  one  and  from  120  spheroids  on  days  three-­five.  cDNA  samples  were  
generated   and   then   analysed   by   QPCR.   Expression   of   TFEB   for   was   normalised   to  
expression  of   the  housekeeping  gene  GAPDH  and  made   relative   to  expression   levels  
the   2D   sample.   Fold   changes   were   calculated   as   2-­ddCt.   Data   from   two   HDF   cell  





























Figure  3.9.  Western  Blot  Analysis  of  LAMP-­1  Expression  in  2D  and  3D  HDFs  
using  β-­tubulin  as  a  Control.  
HDFs  were  cultured  as  monolayers  and  as  30,000  HDF  spheroids   for   four  days.  Total  
protein   was   extracted   and   analysed   using   western   blot.   The   membrane   was   probed  
using   anti-­LAMP-­1   and   anti-­   β-­tubulin   antibodies.   The   density   was   measured   using  
Image   J   software,   3D   levels  were  measured   relative   to   2D  and   then  normalised   to   β-­

































Figure  3.10.  Transmission  Electron  Microscopy  Images  of  2D  and  3D  HDFs.  
HDFs  were  cultured  as  a  2D  monolayer  and  as  3D  HDF  spheroids.  The  spheroids  were  then  
sectioned   and   stained   and   examined   by   transmission   electron   microscopy   (TEM).   TEM  
images   show   smaller   rounded   mitochondria   (M)   and   numerous   lysosome   (L)   and  





3.5   Redifferentiation  of  the  3D  HDFs  Into  an  Endothelial-­like  
Cells:  
  
3.5.1     3D  HDF  Network-­like  Formation:  
  
The   potential   of   dedifferentiated   cells   to   become   new   cell   types   is   essential   to  
develop  the  use  of  these  cells  for  regenerative  purposes.  The  fact  that  the  3D  HDFs  
appear   to   be   dedifferentiating   to   what   is   thought   to   be   a   mesoderm-­like   state  
suggests   that   these   cells   should   be   able   to   differentiate   into   cell   types   originating  
from   this   lineage.   The   potential   of   the   3D   HDFs   to   switch   to   different  
mesendodermal   cell   types   was   tested   by   growing   them   in   endothelial   cell  
differentiation  conditions.  HDFs  were  grown  as  monolayers  and  as  30,000  3D  HDF  
spheroids   for   four   days.   The   3D   HDFs   were   then   disaggregated   and   cultured   in  
EGM   on  Matrigel   to   determine   their   ability   to   form   endothelial-­like   cells.   A   typical  
characteristic   of   endothelial   cells   grown   on   Matrigel   is   the   formation   of   vascular  
network-­‐like   structures   (Voyta   et   al.,   1984)   This   is   seen   by   the   multiple   different  
types  of  endothelial  cell   such  as  HUVECs.  The   introduction  of  Matrigel  creates  an  
extracellular   matrix   which   mimics   aspects   of   a   3D   cellular   environment   which  
induces   the   formation   of   capillary-­like   structures   (Kleinman   and   Martin,   2005).  
Initially   the  cells  were  grown   in  EGM1  (Promocell)  which   is  a  specific  medium  that  
does   not   contain   FBS   but   specific   endothelial   cell   growth   supplements   including  
FGF-­2.  The  disaggregated  3D  HDFs  are   plated   at   approximately   500,000   cells/ml  
on   200µl   Matrigel   (see   section   2.7).   Images   of   the   network-­like   structures   were  
taken   using   a   LCM   filter   setting   on   a   Leica   DC   500   microscope   (Figure   3.11).  
Additionally,   after   seven   days   of   3D   HDFs   being   cultured   on   Matrigel,   the   actin  
cytoskeleton  was  stained  using  rhodamine-­phalloidin  to  help  visualise  the  capillary-­
like   structures   and   to   determine   the   penetrative   distance   of   the   3D  HDFs   (Figure  
3.12)  Four   z-­stacks  were   taken   from   four  different  wells  and   the  average  distance  
was  measured  was  around  322μm.  The  3D  HDFs  took  approximately  seven  days  to  
form   networks   whereas   the   2D   HDFs   initially   spread   across   the   well   and   then  
retracted   to   form   aggregations   on   the   Matrigel   (Figure   3.11b).   The   formation   of  
these   capillary-­like   structures   by   3D   HDFs   suggests   they   are   capable   of  
differentiating  into  an  endothelial-­like  cell.  The  networks  formed  by  the  3D  HDFs  and  
HUVECs  are  different  as  HUVECs  are  known  to  form  capillary-­like  structures  on  the  
surface  of  the  Matrigel.  However,  the  3D  HDFs  appear  to  have  increase  penetrative  
potential   and   form   networks   through   approximately   300µm   of   Matrigel.   The   cells  




connections   whereas   HUVECs   appeared   to   aggregate   together   to   form   longer  
capillary-­like  structures.  
	  
Figure  3.11.  LCM  images  of  3D  HDFs  Grown  on  Matrigel  in  Endothelial  Cell  
Media  1.  
LCM   images   of   3D  HDFs   cultured   in  Matrigel   for   seven   days   (a).   LCM   images   of   2D  
HDFs  cultured  on  Matrigel  for  seven  days  (b).  Images  were  taken  using  LCM  filter  on  a  
Leica  DC  500  scale  bar  is  50µm.  Experiment  was  replicated  6  times  and  repeated  once  













Figure  3.12.  Maximum  Projection  Intensity  Images  of  Rhodamine-­Phalloidin  
Stained  3D  HDFs  Grown  on  Matrigel  in  Endothelial  Cell  Media  1.  
3D   HDFs   cultured   in   Matrigel   for   seven   days   and   cells   were   stained   with   rhodamine-­
phalloidin.  Rhodamine-­phalloidin  images  were  taken  as  a  z-­stack  due  to  the  formation  of  a  
multi-­layered  3D  network   and   the   images  were   combined   to   create   a  maximum   intensity  
projection,   scale   bar   is   200µm   (a).   Using   the   rhodamine-­phalloidin   z-­stack   images   the  
penetration  distance  of   the  cells  could  be  measured,  scale  bar   is  100  µm  (b).  Experiment  
was  replicated  3  times  in  separated  wells  and  images  are  representative  of  each  replicate.  





Vascular   endothelial   growth   factor   (VEGF)   and   in   particular   VEGF-­A,   is   a   key  
regulator  of  vasculogenesis,  VEGF-­A  signals   through  fms-­related  tyrosine  kinase-­1  
(Flt-­1)   or   kinase   insert   domain   receptor   (KDR).   It   also   interacts   with   co-­receptors  
neuropilin-­1  and  -­2  (Nrp-­1,  Nrp-­2)  (Marcelo  et  al.,  2013).  VEGF  has  been  shown  to  
be  a  key  regulator  in  endothelial  cell  differentiation  as  shown  in  in  vitro  differentiation  
experiments   (Nourse  et  al.,   2010).  Many   reports   suggest   that  50ng/ml  of  VEGF   is  
the   optimal   concentration   for   endothelial   cell   differentiation   and   production   of  
functional  endothelium  and  it  has  also  been  shown  that  a  combination  of  VEGF  and  
FGF-­2   is   essential   for   endothelial   cell   differentiation,   as   explained   in   the  
Introduction,  section  1.6.   (Chen  et  al.,  2009;;  Wang  et  al.,  2010,  2013).  This  would  
suggest   that   the   addition   of   VEGF   to   the   protocol   could   potentially   promote   the  
induction  of  endothelial  cell  differentiation  from  3D  HDFs.    
This  was  also  hypothesised  of  Bone  Morphogenetic  Protein  4  (BMP4)  which  is  a  key  
signalling   component   that   is   important   for   mesoderm   specification   but   also  
mesoderm   differentiation   toward   endothelial   and   haematopoietic   cell   fates.   BMP4  
along   with   FGF-­2   is   known   to   play   a   role   in   cell   commitment   towards   a   KDR+  
progenitor   cell  which   then   had   the   capacity   to   differentiate   down  a   venous/arterial  
development  path  or   the   lymphogenesis  pathway.  BMP4  knock  out  mice  embryos  
showed   that   mesoderm   formation   does   not   occur   without   BMP4   (Winnier   et   al.,  
1995).   It   has   been   shown   that   short-­term   BMP4   treatment   initiated   mesoderm  
induction  at  high  efficiency  in  hES  cells  (Zhang  et  al.,  2008).  This  would  suggest  that  
combination   of   BMP4   and   VEGF   could   promote   differentiation   towards   a   mixed  
population  of  endothelial-­like  cells.  BMP4  is  present  to  initiate  mesoderm  formation  
focussing  towards  endothelial/haematopoietic  progenitor  cell  and  VEGF  is  known  to  
promote  endothelial  differentiation.  
The   network   forming   experiment   was   repeated   using   EGM2   (Promocell)   which  
contained  20ng/ml  IGF1,  0.5ng/ml  VEGF  and  10x  the  original  concentration  of  FGF-­
2   (10ng/ml).   Additionally,   this   media   was   supplemented   with   increased   VEGF  
(50ng/ml)   and   BMP4   (10ng/ml)   separately   and   combined   to   test   whether   these  
supplements   would   improve   the   formation   of   the   network-­like   structures.   The  
disaggregated  3D  HDFs  were  grown  in  EGM2  and  the  supplemented  forms  EGM  3-­
5  the  method  and  concentrations  of  supplements  added  can  be  found  in  section  2.7.  
Brightfield   images   were   taken   at   5x   magnification   and   20x   magnification   of   the  
network  structure  at  24  hours  (Figure  3.13).  The  additional  supplements  appeared  to  
have   decreased   the   time   required   for   the   3D  HDFs   to   form   networks.   There   was  




additional   supplements.   The   3D   HDFs   now   formed   networks   that   appeared  more  
like   aggregates   of   cells   forming   larger   longer   networks.   The   addition   of   a  
combination  of  VEGF  and  BMP4  also  showed  sprouting  along  the  networks  which  is  
indicative  of  endothelium  (Figure  3.13).  The  behaviour  of   these  3D  HDFs  is  similar  
to   that   of  HUVECs   grown   in   a   same   condition.   The   2D  HDFs   grown   in   the   same  
conditions   formed   huge   cell   aggregates   and   no   networks   with   and   without   the  
additional   supplements   images   were   taken   using   the   Leica   LCM   setting   as   it  














Figure  3.13.  Brightfield  Images  of  3D  HDF  Network-­Formation  
Brightfield   images  of  3D  HDFs  cultured   in  Matrigel   for  24  hours   in  different  endothelial  
growth  media  scale  bar  =  250µm  (a)  scale  bar  =  50µm  (b).  Images  were  taken  using  a  
Leica  DC  500  microscope.  Experiment  was   repeated   three   times  and   the  pictures  are  
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Figure  3.14.  Leica  LCM  Images  of  2D  HDFs  Grown  on  Matrigel  
LCM   images   of   500,000   2D   HDFs   cultured   on   Matrigel   for   24   hours   in   different  
endothelial  growth  media.   Images  were  taken  using  the  LCM  filter  on  a  Leica  DC  500,  
scale  bar  =  250µm.  Experiment  was  repeated  twice  and  the  pictures  are  representative  


















3.5.2   Comparison  of  Network  Structures  of  3D  HDFs:    
  
The  brightfield  images  of  the  3D  HDFs  grown  in  endothelial  growth  conditions  were  
used  in  order  to  measure  the  lengths  and  the  widths  of  the  capillary-­like  structures  in  
order   to   compare   the   networks   formed   (Figure   3.15).   The   addition   of   high  
concentrations   of   VEGF   all   showed   statistically   significant   differences   when   the  
EGM   media   is   altered.   EGM2   produced   shortest   capillary-­like   structures   and   the  
addition  of  high  concentrations  of  VEGF  appeared  to  produce  the  longest  capillary-­
like  structures.  It  would  also  appear  that  the  addition  of  BMP4  has  an  effect  on  the  
length  of  the  capillaries  as  they  appear  to  increase  with  the  additional  BMP4.    
The  width   of   the   capillary-­like   structures  were   also  measured   using   the   brightfield  
images.   The   capillaries   made   by   the   cells   grown   in   EGM2   were   the   shortest   but  
were   measured   to   be   the   second   thickest.   Whereas   the   addition   of   high  
concentrations  of  VEGF  that  showed  the  longest  capillaries  were  also  the  thinnest.  It  
would  also  appear  that  the  addition  of  BMP4  increases  the  width  of  the  capillary-­like  
structures.  It  could  be  speculated  the  addition  of  certain  concentrations  of  VEGF  and  





Figure  3.15.  Quantification  of  3D  HDF  Capillary-­like  Structures.  
HDFs  were  cultured  as  3D  spheroids  with  initiating  cell  numbers  of  30,000  cells  for  up  to  
four  days  in  culture.  The  cells  were  then  disaggregated  as  described  in  section  2.6.  and  
grown   on  Matrigel   in  EGM2  and   supplemented  EGM2   for   24   hours.   The   capillary-­like  
structures  were  measured  using  Image  J  to  compare  their  length  (a)  and  width  (b)  n=35  





































3.5.3   AcLDL  Uptake  of  the  3D  HDFs:  
  
Finally,   another   test   that   was   done   to   determine   whether   the   3D   HDFs   have  
functional  characteristics  similar  to  the  HUVECs  was  to  measure  the  acLDL  uptake  
of  the  3D  HDFs.  The  3D  HDFs  and  HUVECs  were  grown  on  Matrigel  as  described  
in  section  2.9  until  the  networks  form  and  acLDL  was  then  added  and  incubated  for  
five  hours.  The  results  show  that  the  3D  HDFs  are  not  up  taking  acLDL  to  the  same  
level  of  the  HUVECs  (Figure  3.16).  This  would  suggest  that  despite  the  fact  a  small  
amount  of  acLDL  uptake  can  be  seen  the  cells  do  not  have  all  the  characteristics  of  
endothelial  cells  and  suggests  alterations  to  the  differentiation  protocol  could  lead  to  
the   3D   HDFs   having   more   endothelial-­like   characteristics   and   higher   expression  





Figure  3.16  acLDL  Uptake  of  3D  HDFs  Grown  in  EGM1.  
3D  HDFs  cultured  in  Matrigel  for  seven  days  and  HUVECS  cultured  in  Matrigel  for  1  day  
and  both  were  incubated  with  50µl  Dil-­acLDL  for  five  hours.  The  images  were  taken  as  a  
z-­stack   due   to   the   formation   of   a   multi-­layered   3D   network   and   the   images   were  






3.5.4   3D  HDF  Expression  of  Endothelial  Markers:  
  
Due  to  the  fact  the  3D  HDFs  were  able  to  form  extensive  networks  on  Matrigel,  the  
cells  were  tested  for   their  expression  of  markers  typically  expressed  by  endothelial  
cells.   2D   and   3D   HDFs   grown   on   Matrigel   in   EGM1,   EGM2   and   EGM2   with  
additional  supplements  (section  2.7)  were  cultured  and  RNA  was  taken  at  48  hours  
and   prepared   as   described   in   section   2.2.   Using   QPCR   the   expression   levels   of  
early  endothelial  markers  such  as  Kinase   Insert  Domain   (KDR),  Neuropilin-­1   (Nrp-­
1),  Neuropilin-­2  (Nrp-­2),  Activin  receptor-­like  kinase  (ALK1),  Ephrin-­type  B  receptor  
4  (EphB4)  and  vascular  endothelial  Cadherin  (VE-­Cadherin)  were  analysed.    
Cadherins  are  one  of  the  major  cell  adhesion  molecule  families  and  they  are  defined  
by   the   typical   extracellular   cadherin   domains   (EC-­domain)   that   are   capable   of  
binding  through  a  homophillic  calcium-­dependent  interaction.  There  are  two  types  of  
cadherins   type   I  such  as  E-­  N-­  P-­  and  C-­cadherin  and   type   II  which   lack   the  HAV  
motif  which  is  a  binding  motif  found  in  the  EC  domain  of  type  I  cadherins.  It  is  to  this  
group   that   VE-­cadherins   belong   (Vestweber,   2008).   VE-­Cadherin   is   known   to  
interact   with   KDR  which   is   important   for   cell   signalling   events.   This   is  most   likely  
critical   for   counter   regulation   of   VEGF-­stimulated   proliferation   and   regulation   of  
apoptosis  (Carmeliet  et  al.,  1999;;  Lampugnani  et  al.,  2003).  The  KDR-­VE-­cadherin  
complex   is  also   important  during   the   regulation  of  VE-­cadherin  mediated  adhesion  
during  VEGF-­stimulated  angiogenic  processes  (Lambeng  et  al.,  2005).  Increases  in  
tyrosine  phosphorylation  of  KDR  and  VE-­cadherin  by  VEGF  has  been  proven  to  be  
involved  in  endothelial  cell  migration  as  well  as  tubular   formation  (Lin  et  al.,  2003).  
The  expression  of  VE-­Cadherin  was  either  maintained  at  2D   levels  or  upregulated  
slightly.   The   EGM   containing   both   BMP4   and   the   increased   VEGF   concentration  
had   the   highest   VE-­Cadherin   expression   which   was   seen   to   be   around   1.5-­fold  
(Figure  3.17a).  This  is  only  a  moderate  increase  and  other  factors  had  much  higher  
fold  changes.  However,  EGM  containing  only  high  concentrations  of  VEGF  showed  
a  decrease  in  VE-­Cadherin  expression.  This  suggests  the  BMP4  is  essential  for  the  
endothelial  differentiation  protocol.  
Activin  receptor-­like  kinase  (ALK1)  is  a  type  I  receptor  for  transforming  growth  factor  
β   (TGFβ)   and   is   important   in   determining   vascular   development   during  
angiogenesis.  ALK1  was  found  to  be  expressed  in  blood  vessels  and  through  knock-­
out   experiments   it   has   been   shown   that   a   lack   of   ALK1   is   fatal   during   embryonic  
development   due   to   hyperdilation   and   hyperfusion   of   blood   vessels   (Corti   et   al.,  




paradoxical  effect  as  it  has  been  shown  to  have  an  involvement  in  cell  proliferation  
and   tubule   formation   (Valdimarsdottir  et  al.,  2002).  However,  when  a  constitutively  
active  form  is  expressed  in  endothelial  cells,   it   is   found  to  prevent  proliferation  and  
have  an  effect  in  angiogenic  maturation  (Lamouille  et  al.,  2002).  This  suggests  that  
ALK1  has  opposing  roles  that  are  dosage  dependent  during  development.    As  ALK1  
expression  is  restricted  to  endothelial  cells,  receptor  upregulation  of  ALK1  it  can  be  
used   as   a   marker   of   endothelial   differentiation.   The   expression   levels   of   ALK1  
appeared   to   increase   the  most   in   the  media   containing   only   the   additional   BMP4  
where   an   8-­fold   increase  was   seen   (Figure   3.17b).   The   other   forms   of   the  media  
appear   to   show  a  maintenance  of  ALK1  expression   or   have   very  minor   increases  
when  compared  to  the  2D  HDFs.  
Neurophilin-­2   (Nrp-­2)   is   also   found   to   form   a   complex   with   VEGFR2   (KDR)   and  
VEGFR3.   It   is   thought   to   lower   the   activation   threshold   of   these   receptors   to  
increase  sensitivity  to  specific  VEGF  isoforms  (Favier  et  al.,  2006).  Nrp-­2  expression  
has   been   reported   to   be   restricted   to   vein   and   lymphatic   vessel   vascular  
membranes.   It   has   been   shown   to   have   a   prominent   role   in   VEGF   mediated  
angiogenesis.   Nrp-­2   is   expressed   in   early   endothelial   cells   and   can   be   used   to  
determine  whether  the  cells  are  differentiating  to  an  endothelial-­like  cell.  Nrp-­2  has  a  
moderate  increase  in  expression  by  1.5-­fold  in  3D  HDFs  grown  in  unsupplemented  
media  and  the  media  containing  both  VEGF  and  BMP4  (Figure  3.17c).  However,  the  
addition  of  VEGF  and  BMP4  separately  appeared   to   increased   the   levels  of  Nrp-­2  
the  most  by  approximately  3-­fold.  
Neuropilin-­1   (Nrp-­1)   is   known   to  be  expressed   in  very  early  differentiation  of   stem  
cells   that  have  begun   the  process  of   forming  vascular,  haematopoetic  and  cardiac  
precursors.  Nrp-­1   is  known  to  be   involved   in  endothelial  cell  differentiation   through  
its   capacity   to   form  complexes  with  VEGFR1  and  KDR   (VEGFR2)   (Gelfand  et   al.,  
2014).   KDR  as   previously  mentioned   is   a  marker   of   endothelial   cell   differentiation  
through  its  very  important  role  as  a  VEGF  receptor.  Nrp-­1  expression  is  known  to  to  
be   a   marker   for   endothelial   precursors   that   form   functional   vessels   and   its  
expression   coincides   with   Brachyury   expression   (Cimato   et   al.,   2009).   KDR   and  
Nrp-­1   bind   to   create   a   complex   and   enhances   the   ability   of   KDR   to   bind   specific  
VEGF   isoforms   and   VEGF-­mediate   chemotaxis   (Gelfand   et   al.,   2014).   Nrp-­1   has  
been  concluded  to  be  an  early  marker  of  endothelial  cells  and  can  also  be  used  to  
look  at   the  differentiation  of   the  3D  HDFs.  Unsupplemented  medium  showed   very  
little   change   in   Nrp-­1   expression.   The   3D   HDFs   in   the   two   media   with   BMP4  




Eph   receptors   and   their   ligands   comprise   the   largest   family   of   receptor   tyrosine  
kinases.   Eph   receptors   and   their   ligands   are   involved   in   mediating   multiple  
developmental   processes.   They   are   known   to   be   involved   in   neuronal   guidance,  
cardiac  development,  tissue-­border  formation  and  are  expressed  by  endothelial  cells  
(Gerety   et   al.,   1999;;   Hamada   et   al.,   2003;;   Wang   and   Anderson,   1997).   EphB  
receptors   have   been   shown   to   have   crucial   roles   in   vascular   morphogenesis   as  
evidenced  using  knock-­out  experiments  (Hamada  et  al.,  2003).  These  experiments  
have  shown   that  EphB   is  essential   since  arterio-­venous  differentiation   is  disturbed  
when  EphB  receptors  are  not  present.  Ephrin-­B2  is  a  marker  of  arterial  endothelial  
cells   and  EphB4   is   expressed   by   venous   endothelial   cells   (Hamada   et   al.,   2003).  
This  was  shown  by  experiments  involving  signalling  between  EphB4  and  Ephrin-­B2  
ligand  which  have  shown  they  are  involved  in  mediating  signalling  between  arterial  
and  venous  endothelial  cells  to  allow  proper  morphogenesis  and  differential  growth  
of  arterial  and  venous  vessels  (Hamada  et  al.,  2003;;  Wang  et  al.,  1998).  This  allows  
us  to  use  EphB4  as  a  marker  of  endothelial  cell  differentiation  and  more  specifically  
venous  endothelial  cell  differentiation.  The  3D  HDFs  grown  in  the  VEGF  and  BMP4  
supplemented  EGM  showed  a  73-­fold  increase  in  EphB4  expression  in  comparison  
to  the  2D  HDFs  (Figure  3.17e).  It  would  appear  that  the  addition  of  both  BMP4  and  
VEGF   is   essential   to   the   high   EphB4   expression   as   the   other   growth   conditions  
showed  very  little  EphB4  change.  
KDR  was  previously  used  to  identify  whether  the  3D  HDFs  were  dedifferentiating  to  
a  mesoderm  specific  cell.  KDR  is  also  typically  found  on  endothelial  progenitor  cells  
and  on   fully  differentiated  endothelial  cells.  Maintenance  of  KDR  expression   in   the  
3D   HDFs   grown   in   endothelial   cell   growth   conditions   would   provide   supporting  
evidence   that   the   cells   are   not   regaining   their   typical   HDF   characteristics   and   an  
upregulation  would   indicate   that   the  3D  HDFs  are  differentiating   to  an  endothelial-­
like  cell.  However,  by  this  time  KDR  expression  had  decreased  below  the  levels  of  
2D   HDFs   and   was   shown   to   decrease   to   about   0.5-­fold   (Figure   3.17f).   However,  
through  the  addition  of  50ng/ml  VEGF,  10ng/ml  BMP4  and  20ng/ml  of   IGF1   it  was  
possible  to  increase  the  levels  of  KDR  to  115-­fold  (Figure  3.17f).  This  fold-­change  is  
higher   than   the  KDR   expression   increase   in   just   3D  HDFs   before   being   grown   in  
endothelial  growth  conditions  which  suggests  they  are  beginning  to  differentiate  and  
that  the  additional  supplements  are  necessary  for  endothelial  differentiation.    
The  addition  of  both  VEGF  and  BMP4  appears   to  have  been   the  most   successful  
endothelial  differentiation  media.  The  3D  HDFs  were  capable  of  forming  network-­like  




and  thickest  which  could  suggest  they  are  the  most  stable.  The  3D  HDFs  grown  in  
EGM2  with  additional  VEGF  and  BMP4  also  had   the  highest  VE-­Cadherin,  EphB4  
and  KDR  fold-­changes.  The  other  endothelial  markers  also  all  appeared  to  increase  
with  the  exception  of  ALK1.  This  suggests  these  endothelial  growth  conditions  were  












Figure  3.17.  QPCR  Analysis  of  Change  in  Expression  of  Endothelial  Markers  in  
3D  HDFs  Grown  in  Endothelial  Growth  Conditions  
HDFs  were  cultured  as  2D  monolayers  and  3D  spheroids  with  initiating  cell  numbers  of  
30,000   cells   for   up   to   five   days   in   culture.   The   cells   were   then   disaggregated   as  
described   in   section  2.6.   and  grown  on  Matrigel   in  EGM,  EGM  with  VEGF,  EGM  with  
BMP4  and  EGM  with  both  VEGF  and  BMP4.  RNA  samples  were  taken  at  48  hours  and  
cDNA  samples  were  generated  and  expression  of  endothelial  cell  markers  VE-­Cadherin  
(a),   ALK1   (b),   Nrp-­2   (c),   Nrp-­1   (d),   EphB4   (e)   and  KDR   (f)   were   analysed   by  QPCR.  
Endothelial  markers  were  normalised  to  expression  of   the  housekeeping  gene  GAPDH  
and  made  relative  to  expression  levels  the  2D  sample.  Fold  changes  were  calculated  as  
2-­ddCt.  Data   from   two  series  of  experiments  were  pooled  and  mean   fold  changes  are  









































































































4   Discussion  
	  
4.1   Characterisation  of  3D  HDFs:  
  
The   experimental   evidence   provided   suggests   that   HDFs   cultured   in   specific   3D  
conditions  dedifferentiated   to  an  early  mesodermal  cell.  Additionally,  evidence  was  
also  provided  showing  that  these  cells  are  then  able  to  redifferentiate  to  endothelial-­
like  cells.  The  TEMs  of  the  3D  HDFs  showed  smaller  rounded  mitochondria  which  is  
different   to   the   2D   HDFs   which   have   an   elongated   tubular   morphology   similar   to  
what  was  seen  in  the  3D  MSCs  (Pennock  et  al.,  2015).  This  could  be  evidence  that  
the   HDFs   are   undergoing   a   similar   metabolic   switch.   However,   there   was   not  
enough   time   to   perform   additional   experiments   to   confirm   the   hypothesis   of   this  
metabolic   switch  by   itself.   The  observation  of   smaller   rounded  mitochondria   is   not  
enough  evidence  to  clearly  establish  a  metabolic  switch  but  leads  to  speculation  that  
it  occurs  in  the  3D  HDFs  which  could  be  confirmed  by  further  experiments.  The  3D  
HDFs   also   express   upregulated   expression   levels   of   Brachyury,   Goosecoid,   KDR  
and  CXCR4  when  compared  to  2D  HDFs.  Thus,  we  can  conclude  that  the  cells  are  
responding  to  the  culture  technique  in  a  similar  manner  to  that  of  the  3D  MSCs  and  
are   potentially   dedifferentiating   to   a   similar   stage   of   cellular   development.   It   is  
proposed   that   the   3D  HDFs   could   have   similar   properties   to   this   early   germ   layer  
specification   to   the   haemangioblast   stage.   This   idea   is   supported   further   by  
observation  that  Goosecoid  expression  is  only  expressed  briefly  during  development  
as  opposed  to  Brachyury  which   is  downregulated  much  later  (Artinger  et  al.,  1997;;  
Blum  et  al.,  1992).    In  3D  HDFs  Brachyury  is  upregulated  approximately  5.5-­fold  in  
the  3D  culture  conditions.  Brachyury  is  a  key  regulator  for  mesoderm  formation  and  
is  expressed  in  all  nascent  mesoderm  and  then  downregulated  when  cells  begin  to  
specify.  It   is  therefore,  essential  to  characterization  of  these  cells,  and  suggests  an  
early   stage   of   mesodermal   development.   Additionally,   Goosecoid   was   also  
upregulated   in   the   3D  HDFs   by   approximately   26.5-­fold   and   is   also   expressed   in  
mesendoderm.   In   comparison   to   the   expression   of   Brachyury,   Goosecoid   is   only  
expressed  for  a  short  period  of  time  during  development,  which  would  suggest  that  
the  3D  HDFs  are  broadly  equivalent   to  an  early  mesendodermal  cell   type.  Another  
reason  which  suggests  that  these  cells  are  at  the  pre-­haemangioblastic  stage  is  the  
finding  that  they  express  upregulated  levels  of  KDR  by  approximately  61-­fold.  KDR  
is  typically  expressed  in  cells  destined  to  become  haemangioblastic  cells  which  will  
then   carry   on   to   form   haematopoietic   stem   cells   and   endothelial   cells.   In   the  




are   known   to   be   expressed   (Fehling,   2003).   However,   despite   the   high   level   of  
expression   of   Brachyury   in   early   mesoderm   formation,   it   is   downregulated   at   the  
start   of   the   haemangioblastic   stage   in   order   to   aid   in   cell   specification.   This  
downregulation  of  Brachyury   is  controlled  by  KDR  expression.  Further  evidence  of  
3D   HDF   dedifferentiation   is   supported   further   by   the   findings   concerning  
upregulation   of   CXCR4   which   is   typically   expressed   during   development   of  
haematopoietic  stem  cells  and  specific  endothelial  cells  and  has  been  shown  to  be  a  
marker   of   the   haemangioblast   (McLeod   et   al.,   2006).   CXCR4  mRNA   and   protein  
expression   was   upregulated   in   3D   HDFs   versus   2D   HDFs   and   was   shown   to   be  
expressed   throughout   the   spheroid   by   immunostaining.   In   addition   mRNA  
expression  of  the  CXCR4  ligand  and  stromal  marker  CXCL12  decreased  in  the  3D  
HDFs.   Further   analysis   of   the   mesodermal   markers   could   be   done   in   order   to  
quantify   the  number  of  cells   that  are  dedifferentiating.  Collectively,  however,   these  
analyses   of   marker   expression   do   support   the   dedifferentiation   from   a   fully  
differentiated  adult  cell  to  an  early  mesoderm-­like  status.    
	  
4.2   Autophagy  Levels  in  the  3D  HDFs  	  
Previous  work  with  MSCs  has  suggested  that  autophagy  could  play  a  principal  role  
in  3D-­induced  dedifferentiation   in  vitro  (Pennock  et  al.,  2015).  It  was  proposed  that  
specific  3D  culture  conditions  helped  to  control  autophagy  at  a  sub-­lethal   level  that  
favoured   rejuvenation   and   promoted   cellular   reorganisation   and   clearance   of   the  
cytoplasmic   components.   The   link   between   dedifferentiation   and   autophagy   is  
becoming   better   understood.   It   has   been   shown   in   vitro   that   cells   that   undergo  
induction  of  pluripotency  also  have  increased  levels  of  autophagy  (Menendez  et  al.,  
2011).  The  mechanism  is  thought  to   involve  the  removal  of  mitochondria  that  have  
aged   and   are   potentially   producing   damaging   reactive   oxidative   species.   This  
accelerates   the   ability   of   the   cells   to   switch   to   glycolytic   metabolism   which   is   a  
requirement  for  reprogramming  (Menendez  et  al.,  2011).  The  results  presented  here  
also   provide   evidence   for   an   increase   in   autophagy   in   HDFs   grown   using   the   3D  
culture   technique.  This  was   indicated  by   the   increased  mRNA  expression  of  TFEB  
an  autophagy  master  gene,  and  the  increased  expression  of  the  lysosomal  LAMP-­1  
protein;;   both   these   observations   were   also   made   previously   in   the   3D   MSCs  
(Pennock  et  al.,  2015).    Other  proteins  were  analysed  in  the  3D  MSCs  such  as  the  
LC3:LC2   ratio.   This   could   be   done   in   the   future   in   the   3D  HDFs   as   it   gives  more  




TEMs   were   also   taken   of   2D   and   3D   HDFs   which   provided   visual   evidence   of  
intracellular   alterations.   The   primary   differences   between   the   two   culture  methods  
can   be   seen   by   the   increased   numbers   of   autophagosome-­   and   lysosome-­like  
structures  throughout  the  3D  HDFs,  which  were  absent  in  2D  HDFs.  However,  due  
to   the   fact   the   TEMs   were   only   visually   interpreted,   the   structures   could   be   fully  
identified   by   staining   for   typical   autophagy-­related   organelles   such   as   lysosomes.  
There  also  appeared  to  be  more  debris  surrounding  the  3D  HDFs  when  compared  
to  the  2D  HDFs,  the  nature  of  which  is  yet  to  be  determined.  The  results  regarding  
the  increase  in  autophagy  for  3D  HDFs  are  at  a  preliminary  stage.  Therefore,  more  
experiments  would  be  needed  to  confirm  that  autophagy  levels  are  increasing  in  the  
3D   HDFs.   However,   due   to   the   fact   the   3D   MSCs   have   been   shown   to   have  
increased   levels   of   autophagy   through   a   variety   of   techniques   (Pennock   et   al.,  
2015),   we   can   hypothesise   that   3D  HDFs   also   undergo   a   similar   dedifferentiation  
process  through  controlled  autophagy.    
Furthermore,   the  combination  of   the  results  showing  spheroid  condensation,  which  
is   evidence  of   reversal   to   an   early  mesoderm-­like   cell   type   corresponding  with   an  
upregulation   of   autophagy.   This   strongly   suggests   that   the   3D   HDFs   and   the   3D  
MSCs  follow  the  same  or  closely  related  dedifferentiation  process.  
	  
4.3   Comparisons  with  Natural  Regeneration:  
  
The   blastema   is   a   key   component   in   regeneration   in   multiple   organisms   and   the  
process   appears   to   be   very   similar   between   species.   Planarians   are   a   type   of  
flatworm  that  is  capable  of  regenerating.  Planarians  have  the  three  germ  layers  and  
are  acoelomate  (solid  body  with  no  body  cavity)  (Reddien  et  al.,  2005).  Planaria  can  
be  dissected  and  then  the  separate  pieces  can  regenerate  into  a  complete  organism  
(Reddien  and  Sánchez  Alvarado,  2004).  This  is  also  done  through  the  formation  of  a  
blastema   similar   to   the   process   of   regeneration   used   by   newts   and   salamanders  
(Reddien  and  Sánchez  Alvarado,  2004;;  Reddien  et  al.,  2005).  The  method  in  which  
blastemal  regeneration  occurs  is  still  not  fully  understood.  However,  specific  aspects  
have  been  elucidated  due  to  studies  in  multiple  lower  organisms  and  similarly  to  the  
blastema  formation  in  zebrafish,  it  has  also  been  shown  that  autophagy  plays  a  role  
in   planarian   regeneration   (Reddien   and   Sánchez   Alvarado,   2004).   Broad  
comparisons  can  be  made  between  the  3D  in  vitro  culture  model  used  here  and  the  
formation  of   the  blastema  during   limb   regeneration.  Blastemal   cells  are   thought   to  




dedifferentiated   to   a  multipotent   stem  cell.   Therefore,   the   cells   are   not   classed  as  
pluripotent   and   cannot   form   a   whole   new   embryo.   This   is   also   because   the   cells  
retain  memory  of   their   type  as  they  enter   the  blastema  structure  and  therefore  can  
only  become  cell   types   from   that  specific   lineage   (King  and  Newmark,  2012).  This  
probably   accounts   for   regeneration   of   the   limb  without   the   formation   of   unwanted  
tissues,   which   is   a   property   of   pluripotent   stem   cells.   Interestingly,   both   the   3D  
MSCs  and  3D  HDFs  have  increased  but  low  level  mRNA  expression  of  pluripotency  
factors  which  differs  to  blastemal  cells  which  have  not  been  shown  to  express  Oct4  
or   Nanog.   However,   blastemal   cells   been   shown   to   have   upregulated   Sox2  
expression  (Monaghan  et  al.,  2012).  Another  broad  similarity  between  the  3D  HDFs    
and  blastemal  cells   is  upregulated  mesodermal  markers   including  Brachyury,  KDR  
and   CXCR4.   This   increased   mesodermal   marker   expression   corresponds   with  
analyses  of  blastemal  cells  in  axolotls,  which  has  shown  that  certain  processes  are  
upregulated  including  mesodermal  development  (Monaghan  et  al.,  2012).      
An  interesting  aspect  that  has  not  been  studied  extensively  is  the  role  of  autophagy  
in   blastemal   cells   during   regeneration   in   multiple   organisms   including   planarian  
regeneration   and   zebrafish   caudal   fin   regeneration.   It   has   been   shown   using  
autophagy-­defective   zebrafish   that   there   was   more   apoptotic   cell   death   and   the  
surviving   cells   then   failed   to   express   the   markers   typically   expressed   during  
differentiation   to   form   the   fin   (Varga  et  al.,  2014).  They  were  also   incapable  of   re-­
growing   the   surgically   removed   fin   which   provides   supporting   evidence   that  
autophagy   is   a   key   process   in   injury-­induced   regeneration   in   lower   organisms  
(Varga   et   al.,   2014).   Evidence   has   also   been   provided   showing   that   increased  
numbers  of  autophagosomes  are  seen  during  Hydra  tip  regeneration  (Galliot,  2006)  
and   treating  Hydra  with  autophagy   inhibitors  delays   regeneration.   It   is   thought   that  
the  stress  of  amputation  causes  the  increase  in  autophagy.  However,  due  to  the  fact  
that  a  large  amount  of  autophagy  causes  rapid  cell  death,  it  is  necessary  for  Hydra  
to   limit   the   amount   of   autophagy.   Although   there   are   fewer   similarities   between  
Hydra   Regeneration   and   the   3D   system   there   are   still   a   few   parallels.   Both   3D  
MSCs  and  3D  HDFs  have  shown  evidence  of   increased  levels  of  autophagy  which  
suggests   they   could   be   undergoing   a   similar   process   and   it   is   also   thought   to   be  
controlled  through  time  and  size  in  culture.  Additionally,  the  3D  MSCs  were  grown  in  
3D  with  bafilomycin  which  prevents  autophagy  from  occurring  and  it  was  seen  that  
the  spheroids  do  not   form  properly  suggesting  that  autophagy  is  a  key  regulator  of  
3D  culture  based  dedifferentiation  (Pennock  et  al.,  2015)  which  is  similar  to  the  need  




Clearly   there   remain   differences   between   blastemal   cells   and   3D   HDFs   as   the  
processes  are  not  identical  and  the  methods  used  to  generate  3D  HDFs  was  not  an  
attempt   to   mimic   blastemal   formation.   Similarities   include   spheroid   condensation,  
increased  Sox2  expression,  mesodermal  marker  upregulation  and  the  necessity  for  
increased   autophagy   are   nevertheless   observed.   Therefore,   the   process   in   which  
blastemal  cells  are  dedifferentiating  could  provide  further  clues  about   the  nature  of  
the  process  that  is  occurring  in  the  spheroid  structure.  
	  
4.4     Endothelial-­like  Cell  Differentiation:  
  
The  ability  for  the  dedifferentiated  3D  HDFs  to  re-­differentiate  into  different  cell  types  
is  necessary   to   test   the  dedifferentiated  status  of   the  3D  HDFs  and   to  explore   the  
potential  for  new  cell  therapies.  As  the  3D  HDFs  display  early  mesodermal  features,  
the   differentiation   protocol   chosen   was   for   endothelial   cell   differentiation.   The  
endothelium   is   a   single   cell   layer   that   lines   blood   vessels   and   a   key   factor   for  
inflammatory   responses,  vasomotor   tone  and  vascular  permeability.   It  also  plays  a  
pathogenic   role   in   cardiovascular   diseases   such   as   atherosclerosis   and   its  
consequences,   such   as   heart   attacks   and   strokes.   Stem   cell   biology   potentially  
opens   up   new   opportunities   to   understand   endothelial   development   and   function  
and   offers   the   opportunity   to   produce  more   of   this   tissue   for   use   in   therapy.   This  
could   also   include   preventative  measures   to   strengthen   or   rejuvenate   the   existing  
endothelium.  This  has  previously  been  referred  to  as  therapeutic  angiogenesis  is  a  
new  approach  to   treating  cardiovascular  disease  and  cardiomyopathy  (Reed  et  al.,  
2013).    
iPSC  differentiation  to  both  early  endothelial  cells  and  mature  endothelial  cells  such  
as  the  cells  found  in  the  endothelium  has  been  achieved  by  many  laboratories  (Choi  
et  al.,   2009;;  Homma  et  al.,   2010;;  Kurian  et  al.,   2013;;  Li  et  al.,   2011).   It   has  been  
shown  that  endothelial  differentiation  using  iPSCS  requires  an  initial  differentiation  to  
a   mesodermal   progenitor   or   endothelial   progenitor   cell   and   can   then   be  
differentiated   further   into   endothelial   progenitor   cells   or   mature   endothelial   cells.  
However,   this  process  can   take  up   to   two  weeks   to  develop  endothelial  progenitor  
cells   (Asahara   et   al.,   1997;;  Choi   et   al.,   2009;;  Hristov   et   al.,   2003;;  Marcelo   et   al.,  
2013).  Additionally,  having  to  produce  a  progenitor  cell  usually  requires  the  need  to  
sort   for   cells   expressing   cell   surface   markers   in   order   to   generate   a   more  




a   lengthy   and   inefficient   process.   The   3D   HDFs   were   used   in   an   endothelial   cell  
differentiation   protocol   in   an   attempt   to   create   an   early   mixed   population   of  
endothelial-­like   cells.   The   need   for   an   initial  mesodermal   progenitor   differentiation  
stage,   followed  by  cell   sorting  was  avoided  due   to   the   fact   that   the  cells  were  not  
dedifferentiated  to  a  pluripotent  state.    
The  ability  for  endothelial  cells  to  form  networks  on  Matrigel  is  well  known  and  used  
to  characterize  cells  that  have  been  differentiated  alongside  other  characteristics  to  
identify  whether  the  cells  are  phenotypically  similar  to  actual  endothelial  cells  (Belair  
et  al.,  2015).  This   is  essential  as  endothelial  cells  differentiated   in  vitro  need   to  be  
able   to   reproduce   functional   properties   in   order   to   be   characterized   as   an   actual  
endothelial  cell.  It  has  been  shown  previously  that  using  VEGF/KDR  signalling  iPSC  
derived  endothelial  cells  can  produce  networks  on  Matrigel  (Belair  et  al.,  2015)  and  
that  other  artificial  endothelial  cells  such  as   the  HDFs   that  were   transdifferentiated  
are   also   capable   of   forming   these   networks   on  Matrigel   (Sayed   et   al.,   2014).   The  
VEGF/KDR  signalling  molecules  have  been  shown   to  key   in  angiogenesis  and   the  
formation  of  networks  have  been  shown  to  be  dependent  on  VEGF  in  vivo  (Belair  et  
al.,   2015).   The   data   using   the   3D   HDFs   showed   very   limited   capacity   to   form  
networks   in   the   media   without   VEGF   which   would   be   expected   as   there   is   no  
VEGF/KDR   signalling   to   induce   angiogenesis.   The   networks   formed   without   the  
addition   of   VEGF   were   small   and   the   3D   HDFs   appeared   to   form   protrusions   to  
create   cell-­cell   adhesions.   This   is   different   to   the   networks   formed   by   mature  
endothelial  cells  such  as  HUVECs  where  the  individual  networks  consist  of  multiple  
aggregated  HUVECs  to  create  larger  and  longer  capillary-­like  structures  (Saunders  
and  Hammer,  2010).  In  comparison  3D  HDFs  that  were  cultured  in  the  presence  of  
VEGF  were   capable   of   forming   by   24   hours.   This   suggests   the   networks   forming  
were  being  created  due   to   the  VEGF/KDR  signalling,  especially  as   the  cells   in   the  
presence  of  high  concentrations  of  VEGF  appeared  to  have  higher  KDR  expression.  
Lower  and  higher  concentrations  of  VEGF  were  used  and  the  differences  between  
the   networks   can   be   analysed.   These   results   showed   that   dependent   on   what  
supplements   were   added   to   the   media   the   capillary-­like   structures   were   different  
lengths  and  widths.  The  addition  of  VEGF  appears  to  form  longer  thinner  capillaries  
whereas   BMP4   seems   to   form   shorter   slightly   thicker   capillaries.   The   media  
containing   the   combination   of   VEGF   and   BMP4   formed   comparatively   medium  
length  and  the  thickest  capillary-­like  structures.  There  has  not  been  any  explanation  
as  to  why  these  factors  are  having  these  effects  on  the  structure  of  the  networks  and  




endothelial  cells.  The  findings  presented  here  are  extremely  encouraging,  however  
evidence   of   network-­forming   capacity   does   not   alone   demonstrate   an   endothelial  
phenotype.   For   example,   some   cancer   cell   have   been   shown   to   be   capable   of  
forming   networks   on   Matrigel   such   as   brain   tumour   U87   cells,   melanoma   B16F1  
cells  and  breast  cancer  MDA-­MB-­435  cells  in  a  cell  number  dependent  manner.  This  
is   due   to   the   fact   that   some   cancer   cells   have   vasculogenic   activity   that   is  
independent   of   endothelial-­cell   associated   angiogenesis   (Francescone   III   et   al.,  
2011).  Therefore,  other  methods  are  necessary  to  determine  whether  these  cells  are  
re-­differentiating  to  an  endothelial-­like  cell.  Acetylated-­low  density  (acLDL)  uptake  is  
used  as  a  method  to  characterize  endothelial  cells.  The  3D  HDFs  that  were  grown  in  
unsupplemented  media  were  tested  for  their  ability  to  uptake  acLDL.  The  HUVECs  
showed   very   high   acLDL   uptake,   whereas   the   3D   HDFs   did   not   appear   to   have  
increased   uptake   of   acLDL.   If   additional   time   had   been   available,   the   3D   HDFs  
grown   in   EGM   with   VEGF   and   BMP4   would   also   be   tested   for   increased   acLDL  
uptake.   Therefore,   increased   acLDL   uptake   was   not   confirmed   in   the   3D   HDFs  
grown  in  the  improved  endothelial  differentiation  protocol.  Finally,  the  expression  of  
endothelial  markers  is  also  essential  to  confirming  the  3D  HDFs  are  re-­differentiating  
to  endothelial-­like  cells.  The  3D  HDFs  are  shown   to  have   increased  expression  of  
VE-­Cadherin,  Nrp-­1,  Nrp-­2,  ALK1,  EphB4  and  KDR  which  are   factors  known  to  be  
expressed   by   endothelial   cells   and   are   also   used   in   other   differentiation   studies  
(Kurian   et   al.,   2013;;   Sayed   et   al.,   2014).   The   differentiation   protocol   appears   to  
needs   further   optimisation   such   as   additional   time   in   culture   and   additional  
supplements   or   concentration   alterations   in   order   to   potentially   increase   the  
endothelial  marker  expression.  However,   the  evidence  suggests   the  cells  could  be  
on  the  path  to  becoming  an  early  mixed  population  of  endothelial  progenitor  cells.    
  
5   Future  work  and  Conclusions:  
  
Further  experimentation  will   be   required  before   finally  and  conclusively  elucidating  
the  processes  that  occur  in  the  3D  HDFs.  To  analyse  metabolic  shift,  the  cells  could  
be  tested  for  loss  of  mitochondrial  activity  or  the  media  could  be  tested  for  glucose  
uptake  and   lactate  production.  Additionally,  more  functional  evidence  of  autophagy  
could   be   sought   to   confirm   fully   that   the   3D  HDFs   are   also   undergoing   the   same  
autophagy-­mediated  dedifferentiation  process  as  the  3D  MSCs.  However,  the  focus  
of  the  present  research  was  the  overall  process  of  lineage-­conversion  from  HDFs  to  




protocol   requires   some   adjustments   to   improve   the   results.   The   key   factors   that  
need  altering  are  optimising  the  differentiation  protocol  time  and  altering  angiogenic  
supplement   concentration,   particularly   BMP4   and   FGF-­2,   and   potentially   including  
other  factors  to  improve  the  extent  of  endothelial  differentiation,  such  as  TGF-­beta    
The  results  presented  here  suggest  that  adult  HDFs  are  capable  of  undergoing  3D-­
based   dedifferentiation   to   an   early  mesodermal   progenitor   cell-­like   developmental  
stage   (Figure   5.1).   The   3D   HDFs   appear   to   have   increased   levels   of   autophagy,  
which   may   assist   cytoplasmic   restructuring   and   intracellular   renovation.   Finally,  
there   is  evidence   that   the  dedifferentiated  3D  HDFs  are  capable  of  undergoing   re-­
differentiation   into  endothelial-­like  cells,  as  shown  by   the  expression  of  a   range  of  
endothelial   cell   markers   and   most   impressively,   the   formation   of   capillary-­like  
networks  on  Matrigel   (Figure  5.1).  Once   this  protocol  has  been   refined   further   this  




Figure  5.1.  Dedifferentiation  of  Human  Dermal  Fibroblasts  in  3D  Culture.  
HDFs  undergo  dedifferentiation  to  an  early  mesendoderm-­like  state  when  grown  as  3D  
spheroid  cultures  in  a  size-­  and  time-­dependent  manner.  HDFs  are  grown  in  96-­well  U-­
bottomed  plates  in  0.25%  methyl  cellulose  in  DMEM  for  four  days  at  37°C  and  5%  CO2.  
The  mesodermal   progenitor   cells   are   then   capable   of   undergoing   differentiation   to   an  








6   	  Abbreviations:  
  
1.   KDR/VEGFR2:  Kinase  insert  domain/  Vascular  Endothelial  Growth  Factor  
Receptor  2  
2.   Nrp-­1:  Neuropilin-­1  
3.   Nrp-­2:  Neuropilin-­2  
4.   ALK1:  Activin  receptor-­like  Kinase  
5.   EphB4:  Ephrin-­type  B  receptor  4  
6.   VE-­Cadherin:  Vascular  Endothelial  Cadherin  
7.   FGF-­2:  basic  fibroblast  growth  Factor    
8.   EGF:  endothelial  growth  factor  
9.   IGF1:  insulin-­like  growth  factor  1  
10.  BMP4:  bone  morphogenetic  protein  4  
11.  VEGF:  Vascular  endothelial  growth  factor  
12.  LAMP-­1:  Lysosomal-­associated  membrane  protein  1    
13.  TFEB:  Transcription  Factor  EB  
14.  CXCR4:  chemokine  receptor  4  
15.  CXCL12:  chemokine  ligand  12  (Stromal  cell-­derived  factor  1)  
16.  CD31:  cluster  of  differentiation  31  (Platelet  endothelial  cell  adhesion  
molecule)  
17.  p38  MAPK:  p38  mitogen-­activated  protein  kinases  
18.  TLR3:  Toll-­like  receptor  3  
19.  MLV:  murine  leukemia  virus    
20.  HIV:  Human  Immunodeficiency  virus  
21.  BSA:  Bovine  Serum  Albumin  
22.  DMEM:  Dulbecco  Modified  Eagles  Medium  
23.  FBS:  Foetal  Bovine  Serum  
24.  P/S:  penicillin  and  streptomycin  
25.  RPMI:  Roswell  Park  Memorial  Institute  medium  
26.  PBS:  Phosphate  Buffer  Saline  
27.  EGM:  Endothelial  Growth  Media  
28.  ICM:  Inner  Cell  Mass  
29.  HDF:  Human  Dermal  Fibroblast  
30.  MSC:  mesenchymal  stromal  cell  
31.  iPSC:  induced  pluripotent  stem  cell  
32.  mESC:  mouse  embyronic  stem  cell  
33.  HUVEC:  human  umbilical  vein  endothelial  cell  
34.  TEM:  Transmission  Electron  Microscopy  
35.  qPCR:  quantitative  polymerase  chain  reaction  
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